{"text": "Only the pre - coseasonal schedule reduced the medication score as well .At the end of 3 years , both treatments were equally efficacious in reducing total symptoms and lung symptoms and in inducing immunological changes , but during the first 2 years these changes were more pronounced for the continuously treated group [ 63 ] .", "label": "", "metadata": {}, "score": "29.733486"}
{"text": "Patients are asked to maintain the allergen(s ) under the tongue for 1 - 2 mn to allow contact with the oral mucosa .The allergens are subsequently swallowed , as per the \" sublingual - swallow \" procedure .", "label": "", "metadata": {}, "score": "36.132977"}
{"text": "Similar safety was demonstrated with this same ragweed extract solution in a subsequent RDBPC study of 429 patients who received up to 50 mcg of Amb a 1 or placebo [ 92 ] .", "label": "", "metadata": {}, "score": "36.468452"}
{"text": "This suppression was reversible at 4 weeks but not at 12 months by the addition of an anti - IL-10 antibody to the culture medium .", "label": "", "metadata": {}, "score": "36.692863"}
{"text": "Its short- and long - term protection , however , remain to be determined in larger controlled studies with standardized procedures for allergen dosing , schedules , and duration [ 218 ] .", "label": "", "metadata": {}, "score": "37.14466"}
{"text": "Furthermore , 60 % of patients were unaware of any specified appropriate treatment duration , 33 % considered immunotherapy to be without side effects , and only 3.3 % of patients correctly identified all of the allergens to which they were undergoing desensitization [ 338 ] .", "label": "", "metadata": {}, "score": "37.589172"}
{"text": "Another open randomized trial in adults ( 33 patients ) showed that a preseasonal regimen was equivalent in efficacy , as measured by visual analog scale , to the continuous administration [ 65 ] .", "label": "", "metadata": {}, "score": "39.98398"}
{"text": "In these studies and large observational series , side effects were minimal [ 5 - 9 ] .Whilst allergoids have reduced IgE binding ( allergenicity ) which may improve safety , it has also been suggested that they have reduced T cell stimulating activity ( immunogenicity ) which could compromise efficacy [ 12 ] .", "label": "", "metadata": {}, "score": "40.857643"}
{"text": "It is absolutely clear that sublingual formulations of inhalant allergens have an excellent safety profile - perhaps the best of any therapeutic used to treat allergic disease .", "label": "", "metadata": {}, "score": "42.48507"}
{"text": "Here we have examined the relative stimulation of effector and regulatory T cells in vitro by unmodified and depigmented - polymerised allergen extracts , together with the effects of 1\u03b1 , 25-dihydroxyvitamin D3 .", "label": "", "metadata": {}, "score": "42.952263"}
{"text": "All had persistent AR and in 3 cases asthma .None was treated with systemic corticosteroids and all had stable disease controlled with topical treatment only .", "label": "", "metadata": {}, "score": "43.29509"}
{"text": "One of the trials [ 45 ] investigated only immunological parameters and showed a significant effect in the active group but not in the placebo group relative to baseline .", "label": "", "metadata": {}, "score": "43.669086"}
{"text": "Pilot experiments showed the optimal dose of 1\u03b1 , 25-dihydroxyvitamin D3 for expansion of Foxp3 + T cells to be 10 -7 M in this culture system ( data not shown ) .", "label": "", "metadata": {}, "score": "43.68959"}
{"text": "Indeed , post - hoc analyses have confirmed that sensitization status was not a significant covariate in placebo - controlled efficacy in two large trials [ 22 , 23 ] .", "label": "", "metadata": {}, "score": "43.802357"}
{"text": "The specific immunological mechanisms underlying the therapeutic potential of adjuvants and vector systems will be further investigated in upcoming trials .Chemically modified allergen preparations suitable for sublingual administration have been obtained by carbamylation of the native allergen in order to maintain its molecular dimension [ 330 ] .", "label": "", "metadata": {}, "score": "44.961853"}
{"text": "The follow - up duration ranged from 3 months to 3 years , and the average adherence was around 80 % .Although controlled studies and real life represent different situations , the evaluation of adherence in large trials can be taken as a useful model to predict the potential drawbacks of treatment in real life .", "label": "", "metadata": {}, "score": "45.803753"}
{"text": "Dose - response for IL-10 , IL-5 , IFN\u03b3 and IL-17 production by Depig - pol , and native HDM extract - stimulated PBMC at day 5 ( IL-10 ) or day 7 ( IL-5 , IFN\u03b3 and IL-17 ) .", "label": "", "metadata": {}, "score": "46.27261"}
{"text": "Epstein TG , Liss GM , Murphy - Berendts K , Bernstein DI : Immediate and delayed - onset systemic reactions after subcutaneous immunotherapy injections : ACAAI / AAAAI surveillance study of subcutaneous immunotherapy : year 2 .", "label": "", "metadata": {}, "score": "46.5925"}
{"text": "A dose - response study compared the safety of 6 doses of ragweed tablets ( 3 , 6 , 12 , 24 , 50 , or 100 U Amb a 1 ) in 53 subjects with ragweed - induced allergic rhinitis .", "label": "", "metadata": {}, "score": "46.9168"}
{"text": "However , some of them explored new aspects of SLIT .A- HDM SLIT study that recruited patients from primary care practices reported no effect of 2 years of treatment [ 53 ] .", "label": "", "metadata": {}, "score": "47.076057"}
{"text": "Of the 77 trials , 5 were totally negative .Nonetheless , several trials consistently reported efficacy to be dose dependent ( for review see [ 56 ] ) , reinforcing the robustness of the results so far reported in clinical trials .", "label": "", "metadata": {}, "score": "47.340706"}
{"text": "Eifan et al .demonstrated that 1 year of treatment with HDM SLIT was more effective than pharmacotherapy in controlling asthma symptoms , medication , and visual analog scale ( VAS ) scores [ 27 ] . Bronchial- and nasal - specific hyper - reactivity were also reduced .", "label": "", "metadata": {}, "score": "48.004387"}
{"text": "In this case , the authors hypothesized that the amount of allergen given was too low to produce a clinical benefit .Of the mentioned trials , one was performed using the Vienna challenge chamber [ 43 ] and demonstrated that the effect of SLIT begins quite early ( at 4 months ) .", "label": "", "metadata": {}, "score": "48.35543"}
{"text": "Although the standardization of allergen extracts is important for proper clinical dosing and efficacy , variability in the biological potency of some allergen extracts has been described [ 225 ] .", "label": "", "metadata": {}, "score": "48.45893"}
{"text": "The 20 % relative improvement with respect to placebo proposed by WAO addresses this issue [ 233 ] .A further approach based on a \" modified responder analysis \" found that a cutoff of 30 % optimally discriminated between active and placebo treatments during the entire season [ 249 ] .", "label": "", "metadata": {}, "score": "48.496784"}
{"text": "Chapter 4 .Clinical efficacy of sublingual immunotherapy .The majority of these studies were heterogeneous for allergen dose , duration , and patient selection .", "label": "", "metadata": {}, "score": "48.53061"}
{"text": "PBMC ( 2\u00d710 6 /mL ) were cultured with depigmented - polymerised ( Depig - pol ) , depigmented ( Depig ) or native HDM extracts at different concentrations for different times : cytokine production was assessed by CBA , as described in Methods .", "label": "", "metadata": {}, "score": "48.554283"}
{"text": "One approach to reducing the risk of anaphylaxis with SCIT is to modify allergen extracts to reduce IgE binding [ 3 ] .Such allergoids include extracts treated with acid ( \" depigmented \" ) , prior to polymerisation with glutaraldehyde [ 4 ] .", "label": "", "metadata": {}, "score": "48.558174"}
{"text": "There was a progressive reduction in symptoms , as measured with a visual analog scale , which became significant after the first year in the active group .", "label": "", "metadata": {}, "score": "48.726875"}
{"text": "Applying this variable post - hoc to published adult and pediatric trials , the investigators showed a reduction of the observed placebo effect [ 136 ] .", "label": "", "metadata": {}, "score": "48.778477"}
{"text": "At the present time , apart from the use of serum allergen - specific IgE for patient selection [ 39 ] , there are no biomarkers that can be reliably recommended for selection of individual patients in routine practice for immunotherapy , nor for monitoring the response to treatment .", "label": "", "metadata": {}, "score": "48.975212"}
{"text": "Although this approach is scientifically correct , it involves placebo medication for several years at an age when active AIT might be most effective , raising concerns about the ethics of such a strategy , as well as the feasibility [ 271 ] .", "label": "", "metadata": {}, "score": "49.20139"}
{"text": "The use of allergen immunotherapy in the primary care setting [ 166 - 169 ] and the use of allergen extracts for the diagnosis of allergic disease [ 170 , 171 ] have been well documented .", "label": "", "metadata": {}, "score": "49.246445"}
{"text": "Importantly , the measured doses for all SLIT products were below the amounts published by manufacturers from their in - house assays [ 305 ] .", "label": "", "metadata": {}, "score": "49.329117"}
{"text": "Several large multicenter studies , collectively including over 1000 patients , investigated the safety and efficacy of grass and ragweed tablets administered without an updosing phase .", "label": "", "metadata": {}, "score": "49.42003"}
{"text": "Here is a list of possible side effects ( please note that this list is not an exhaustive list ) : .As with any allergy immunotherapy treatment , it is possible a few patients may experience anaphylactic reactions after treatment with allergen extracts .", "label": "", "metadata": {}, "score": "49.71318"}
{"text": "Depigmented - polymerised allergen extracts stimulated less proliferation of PBMC , and reduced effector cell numbers after 7 days in culture than did native extracts .", "label": "", "metadata": {}, "score": "49.931458"}
{"text": "The vast majority of recent , large - scale trials involved two to four months of pre - seasonal treatment before the pollen season in which significant clinical efficacy was observed [ 12 - 16 ] .", "label": "", "metadata": {}, "score": "49.97839"}
{"text": "Formulations of allergens within a particle increase allergen uptake by antigen - presenting cells with a phagocytic activity [ 57 ] .For example , both nanoparticles made from polymerized maltodextrin [ 47 ] or chitosan - based microparticles [ 63 ] were found to enhance in vitro and in vivo allergen capture by tolerogenic oral DCs , thus resulting in a stronger tolerance induction via the sublingual route in murine asthma models .", "label": "", "metadata": {}, "score": "50.027504"}
{"text": "71 - 76 , 1983 .View at Google Scholar .V. Dioszeghy , L. Mondoulet , V. Dhelft et al . , \" Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen - specific response in sensitized mice , \" Journal of Immunology , vol .", "label": "", "metadata": {}, "score": "50.17232"}
{"text": "Citing these studies , the third update of Allergen Immunotherapy : A Practice Parameter [ 102 ] states that : .Immunotherapy can be initiated in young children less than 5 years of age if indicated .", "label": "", "metadata": {}, "score": "50.224247"}
{"text": "Allergen - specific immunotherapy is known to reduce both immediate- and late - phase allergen - induced symptoms , via both humoral and cellular mechanisms [ 41 - 43 ] .", "label": "", "metadata": {}, "score": "50.36522"}
{"text": "In this study , the continuous ( all year long ) regimen started in the preseason .The main results were that in the first pollen season the continuous regimen performed better on symptoms , but starting from the second season , the 2 regimens became more and more similar , so that at the third season no difference could be detected .", "label": "", "metadata": {}, "score": "50.461243"}
{"text": "However , while hypoallergens could in theory represent safer vaccines , there is , as of today , no evidence of their clinical efficacy .With respect to the sublingual route , oral DCs have been shown to express Fc receptors for IgEs , which thus can be used to better address the allergen onto APCs [ 37 ] .", "label": "", "metadata": {}, "score": "50.625286"}
{"text": "Cytokine production ( by CBA ) in 7-day PBMC cultures stimulated with ( A ) HDM or ( B ) Grass depigmented - polymerized ( Depig - pol ) or native extracts with and without 1\u03b1 , 25-dihydroxyvitamin D3 ( 10 -7 M ) .", "label": "", "metadata": {}, "score": "51.042442"}
{"text": "Cytokine production was also maximal at day seven for all cytokines except IL-10 which peaked at day 5 ( data not shown ) .Seven days of culture was therefore used for further comparisons ( except for IL-10 ) .", "label": "", "metadata": {}, "score": "51.32863"}
{"text": "This is demonstrated most graphically for peptide therapy where small allergen peptides which did not cross link IgE nonetheless activated effector T cells and lead to isolated late asthmatic reactions in patients [ 22 ] .", "label": "", "metadata": {}, "score": "51.450085"}
{"text": "Two recent , long - term , large randomized controlled trials have provided evidence for the persistent long - term effect of SLIT for at least 1 [ 120 ] and 2 [ 4 ] years following its discontinuation .", "label": "", "metadata": {}, "score": "51.63624"}
{"text": "Statistical analysis by ANOVA .A Time course for proliferation of Depig - pol , Depig and native HDM extract - stimulated PBMC at a concentration of 100 \u03bcg / mL of each extract .", "label": "", "metadata": {}, "score": "51.894573"}
{"text": "Yukselen A , Kendirli SG , Yilmaz M , Altintas DU , Karakoc GB : Effect of one - year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma : a randomized , placebo - controlled , double - blind , double - dummy study .", "label": "", "metadata": {}, "score": "51.959976"}
{"text": "Oromucosal reactions , considered a SLIT local reaction , were relatively common , affecting up to 75 % of patients , and were seen most frequently in the build - up phase .", "label": "", "metadata": {}, "score": "52.30465"}
{"text": "Sublingual immunotherapy shifts allergic - specific CD4 + T - cells responses from Th2 to Th1 , with the stimulation of IFN \u03b3 -producing T lymphocytes [ 21 , 42 , 43 ] .", "label": "", "metadata": {}, "score": "52.354855"}
{"text": "Six studies were conducted in children [ 40 , 47 - 49 , 53 , 54 ] , and 1 in elderly patients [ 50 ] .", "label": "", "metadata": {}, "score": "52.38676"}
{"text": "Studies with unmodified allergen extracts suggest increased numbers and activity of both CD4 + CD25 hi Foxp3 hi T cells and IL-10 producing T cells after SIT treatment , together with induction of the IL-10-dependent antibody IgG4 [ 17 ] .", "label": "", "metadata": {}, "score": "52.64627"}
{"text": "All showed reduced proliferation of PBMCs stimulated with allergoid when compared to native allergen , and variable reductions in cytokine production .This difference in T cell proliferation between allergoid and native extract was suggested to vary with antigen presenting cell type , although this was not confirmed in a subsequent study [ 15 , 16 ] .", "label": "", "metadata": {}, "score": "52.719734"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years .", "label": "", "metadata": {}, "score": "52.777733"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years .", "label": "", "metadata": {}, "score": "52.777752"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years .", "label": "", "metadata": {}, "score": "52.777752"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years .", "label": "", "metadata": {}, "score": "52.777752"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years .", "label": "", "metadata": {}, "score": "52.777752"}
{"text": "Typical immunotherapy is done by at first injecting small doses of allergen extracts under the skin .Over time , the doses are increased , until at some point your immune system no longer sees those specific allergens as harmful .", "label": "", "metadata": {}, "score": "52.93827"}
{"text": "11 , pp .1705 - 1713 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .O. Iliopoulos , D. Proud , N. F. Adkinson et al . , \" Effects of immunotherapy on the early , late , and rechallenge nasal reaction to provocation with allergen : changes in inflammatory mediators and cells , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "52.98914"}
{"text": "Egert - Schmidt A , Martin E , Mueller J , Schulte M , Thum - Oltmer S : Patients ' compliance towards high - dose hypoallergenic and unmodified SCIT treatment schedules is superior to sublingual immunotherapy [ abstract 1669].", "label": "", "metadata": {}, "score": "53.011124"}
{"text": "A Contour plots showing CD4 + CD25 + FoxP3 hi populations and CD4 + CD25 + Foxp3 low T cells after 7 days culture with depigmented - polymerised ( Depig - pol ) or native grass pollen extracts with and without 1\u03b1 , 25-dihydroxyvitamin D3 ( 10 -7 M ) .", "label": "", "metadata": {}, "score": "53.01422"}
{"text": "24 Severe allergic reactions appear to occur rarely .However , it has not been tested in high - risk asthma patients .5 Another problem is that no allergy extracts for use in sublingual immunotherapy have been officially approved for use in the US , and therefore products available remain incompletely regulated .", "label": "", "metadata": {}, "score": "53.293175"}
{"text": "24 Severe allergic reactions appear to occur rarely .However , it has not been tested in high - risk asthma patients .5 Another problem is that no allergy extracts for use in sublingual immunotherapy have been officially approved for use in the US , and therefore products available remain incompletely regulated .", "label": "", "metadata": {}, "score": "53.293175"}
{"text": "24 Severe allergic reactions appear to occur rarely .However , it has not been tested in high - risk asthma patients .5 Another problem is that no allergy extracts for use in sublingual immunotherapy have been officially approved for use in the US , and therefore products available remain incompletely regulated .", "label": "", "metadata": {}, "score": "53.293175"}
{"text": "24 Severe allergic reactions appear to occur rarely .However , it has not been tested in high - risk asthma patients .5 Another problem is that no allergy extracts for use in sublingual immunotherapy have been officially approved for use in the US , and therefore products available remain incompletely regulated .", "label": "", "metadata": {}, "score": "53.293175"}
{"text": "24 Severe allergic reactions appear to occur rarely .However , it has not been tested in high - risk asthma patients .5 Another problem is that no allergy extracts for use in sublingual immunotherapy have been officially approved for use in the US , and therefore products available remain incompletely regulated .", "label": "", "metadata": {}, "score": "53.293175"}
{"text": "Also , the response to nasal challenge with HDM improved in both groups , but the bronchial HDM challenge dose improved only in the SCIT group , accompanied by a reduction in the post - challenge eosinophil count in broncho - alveolar lavage .", "label": "", "metadata": {}, "score": "53.455208"}
{"text": "Five studies enrolled more than 400 patients [ 40 , 44 , 51 , 52 ] .Dropouts and patient dispositions were reported in all trials , and 11 trials [ 40 , 42 , 44 , 46 , 50 - 55 ] declared a formal sample size calculation .", "label": "", "metadata": {}, "score": "53.48104"}
{"text": "Antibody Responses .After an initial rise , allergen - specific sublingual immunotherapy induces a prolonged decrease in seric IgE levels and prevents the seasonal increase in IgEs associated with exposure to environmental allergens [ 21 , 41 - 43 ] .", "label": "", "metadata": {}, "score": "53.556015"}
{"text": "Two of these 4 experienced anaphylaxis with the first SLIT tablet [ 79 ] .Table 6 .Characteristics of the SLIT - induced anaphylaxis reported in literature .", "label": "", "metadata": {}, "score": "53.642807"}
{"text": "A Contour plots showing CD4 + CD25 + Foxp3 hi populations ( regulatory phenotype ) and CD4 + CD25 + Foxp3 low cells ( effector phenotype ) after 7-day culture with depigmented - polymerised ( Depig - pol ) or native HDM extracts .", "label": "", "metadata": {}, "score": "53.729626"}
{"text": "One patient in the placebo group used it 12 hours after the 137 th dose because of wheezing related to exposure to a grassy field [ 40 ] , and another placebo patient used it in response to what was subsequently deemed to be an anxiety attack .", "label": "", "metadata": {}, "score": "53.858532"}
{"text": "Our data also suggests reduced proliferation and effector cytokine production by PBMC stimulated by Depig - pol extracts compared with native extract , and these findings were confirmed by reduced expansion of cells with effector phenotype in Depig - pol stimulated cultures .", "label": "", "metadata": {}, "score": "54.082916"}
{"text": "It may take years for the \" allergy drops \" to take effect ; though some patients do experience relief after only a few weeks of treatment .", "label": "", "metadata": {}, "score": "54.472054"}
{"text": "5 , pp .2944 - 2952 , 1999 .View at Google Scholar .P. A. Wachholz and S. R. Durham , \" Induction of \" blocking \" IgG antibodies during immunotherapy , \" Clinical and Experimental Allergy , vol .", "label": "", "metadata": {}, "score": "54.66668"}
{"text": "Interestingly , our data both here and in previous studies [ 20 ] suggest that depigmented - polymerised extracts and 1\u03b1 , 25-dihydroxyvitamin D3 both favour Foxp3 hi T cells ( by reducing expansion of effector T cells ) .", "label": "", "metadata": {}, "score": "54.675697"}
{"text": "Bernardini R , Campodonico P , Burastero S , et al .Sublingual immunotherapy with a latex extract in paediatric patients : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "54.72349"}
{"text": "Bernardini R , Campodonico P , Burastero S , et al .Sublingual immunotherapy with a latex extract in paediatric patients : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "54.72349"}
{"text": "Bernardini R , Campodonico P , Burastero S , et al .Sublingual immunotherapy with a latex extract in paediatric patients : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "54.72349"}
{"text": "Bernardini R , Campodonico P , Burastero S , et al .Sublingual immunotherapy with a latex extract in paediatric patients : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "54.72349"}
{"text": "Bernardini R , Campodonico P , Burastero S , et al .Sublingual immunotherapy with a latex extract in paediatric patients : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "54.72349"}
{"text": "Nettis E , Colanardi MC , Soccio AL , et al .Double - blind , placebo - controlled study of sublingual immunotherapy in patients with latex - induced urticaria : a 12-month study .", "label": "", "metadata": {}, "score": "54.80764"}
{"text": "Nettis E , Colanardi MC , Soccio AL , et al .Double - blind , placebo - controlled study of sublingual immunotherapy in patients with latex - induced urticaria : a 12-month study .", "label": "", "metadata": {}, "score": "54.80764"}
{"text": "Nettis E , Colanardi MC , Soccio AL , et al .Double - blind , placebo - controlled study of sublingual immunotherapy in patients with latex - induced urticaria : a 12-month study .", "label": "", "metadata": {}, "score": "54.80764"}
{"text": "Nettis E , Colanardi MC , Soccio AL , et al .Double - blind , placebo - controlled study of sublingual immunotherapy in patients with latex - induced urticaria : a 12-month study .", "label": "", "metadata": {}, "score": "54.80764"}
{"text": "Nettis E , Colanardi MC , Soccio AL , et al .Double - blind , placebo - controlled study of sublingual immunotherapy in patients with latex - induced urticaria : a 12-month study .", "label": "", "metadata": {}, "score": "54.80764"}
{"text": "38 - 44 , 2005 .View at Google Scholar \u00b7 View at Scopus .B. Bohle , T. Kinaciyan , M. Gerstmayr , A. Radakovics , B. Jahn - Schmid , and C. Ebner , \" Sublingual immunotherapy induces IL-10-producing T regulatory cells , allergen - specific T - cell tolerance , and immune deviation , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "54.927074"}
{"text": "View Article .Ring J , Gutermuth J : 100 years of hyposensitization : history of allergen - specific immunotherapy ( ASIT ) .Allergy 2011 , 66 : 713 - 724 .", "label": "", "metadata": {}, "score": "54.997147"}
{"text": "The sublingual route has been initially used for small synthetic drugs ( e.g. , nitroglycerine , opioid analgesics ) for which a fast plasmatic release was needed [ 21 ] .", "label": "", "metadata": {}, "score": "55.00573"}
{"text": "Nonetheless , in the absence of any danger signal , the default response to an antigen administered via the sublingual route is tolerance induction following the induction of Th1/T reg CD4 + T cells [ 21 , 35 ] .", "label": "", "metadata": {}, "score": "55.077415"}
{"text": "These might include : .Chapter 2 Allergen - specific immunotherapy .Chapter 3 Mechanisms of sublingual immunotherapy .Clinical evidence for disease modification and induction of tolerance .", "label": "", "metadata": {}, "score": "55.26329"}
{"text": "Addition of 1\u03b1 , 25-dihydroxyvitamin D3 further favoured Treg , and reduced effector cytokine production , but not interleukin-10 .Conclusions .Depigmented - polymerised allergen extracts appear to favour Treg expansion over activation of effector T cells and this may relate to their demonstrated efficacy and safety in SIT . 1\u03b1 , 25-dihydroxyvitamin D3 further reduces effector T cell activation by allergen extracts and may be a useful adjuvant for SIT .", "label": "", "metadata": {}, "score": "55.329025"}
{"text": "Recently , a small study reported a significantly higher rate of adherence in patients who underwent short educational training than in a group that received only the instructions about SLIT administration [ 318 ] .", "label": "", "metadata": {}, "score": "55.581047"}
{"text": "A study in the United States [ 66 ] compared the efficacy of HDM SLIT in 134 monosensitized or polysensitized patients .After 1 year , symptoms and drug scores decreased significantly in both groups , but no difference between groups was detected .", "label": "", "metadata": {}, "score": "55.616875"}
{"text": "Figure 1 : Fate of the allergen following sublingual administration .Following sublingual immunization , substantial amounts of the allergen bind to epithelial cells within minutes , then cross the mucosa between 15 and 30 minutes .", "label": "", "metadata": {}, "score": "55.65651"}
{"text": "Skin prick testing was used to assess patients before administration of allergen extract solutions .Anecdotally , many of these patients benefitted from this therapy , although it was delivered in a haphazard , random fashion with no true systematic evaluation .", "label": "", "metadata": {}, "score": "55.70723"}
{"text": ": Sub - lingual immunotherapy : World Allergy Organization position paper 2009 .Allam JP , Duan Y , Winter J , Stojanovski G , Fronhoffs F , Wenghoefer M , Bieber T , Peng WM , Novak N : Tolerogenic T cells , Th1/Th17 cytokines and TLR2/TLR4 expressing dendritic cells predominate the microenvironment within distinct oral mucosal sites .", "label": "", "metadata": {}, "score": "55.878067"}
{"text": "Nonetheless , SLIT offers an effective [ 185 , 186 ] , safe [ 86 , 187 - 189 ] , and easy - to - use form of treatment that can be administered in primary care [ 167 , 190 - 192 ] .", "label": "", "metadata": {}, "score": "55.965508"}
{"text": "Allergen immunotherapy involves the regular administration of specific , semipurified allergen extracts , with a view to desensitizing the patient 's allergic reaction when the sensitizing allergen is subsequently or concomitantly encountered under ' natural exposure ' conditions .", "label": "", "metadata": {}, "score": "55.99861"}
{"text": "In a similar pediatric trial , centers with low , moderate and severe disease activity had relative active versus placebo differences of 10 % , 33 % and 34 % , respectively .", "label": "", "metadata": {}, "score": "56.046913"}
{"text": "407 - 419 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .L. Mascarell , L. van Overtvelt , V. Lombardi et al . , \" A synthetic triacylated pseudo - dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route , \" Vaccine , vol .", "label": "", "metadata": {}, "score": "56.07289"}
{"text": "Phase 2 studies .In past clinical experience , allergen doses were frequently adapted to the individual patient ; thus , there are few data on the dose - response relationship of SLIT .", "label": "", "metadata": {}, "score": "56.147762"}
{"text": "The Canadian Society generated a consensus paper on immunotherapy in 2006 [ 285 ] that evaluated SLIT positively as a novel form of allergen administration , but no clear recommendation was given .", "label": "", "metadata": {}, "score": "56.245037"}
{"text": "The identification of disease - eliciting allergens is a prerequisite for accurate prescription of allergen - specific immunotherapy .Molecular allergy diagnosis ( component - resolved diagnosis ) represents a major advance for the selection of patients eligible for AIT .", "label": "", "metadata": {}, "score": "56.279686"}
{"text": "In addition , those allergic patients remained protected for at least two years after stopping the treatment , thus documenting a \" disease - modifying \" effect of SLIT .", "label": "", "metadata": {}, "score": "56.281006"}
{"text": "Second - generation sublingual vaccines are being developed , based upon recombinant allergens expressed in a native conformation , possibly formulated with Th1/T reg adjuvants and/or mucoadhesive particulate vector systems specifically designed to target oral dendritic cells .", "label": "", "metadata": {}, "score": "56.415108"}
{"text": "These CD4 + T cells subsequently migrate into the blood and back to mucosal tissues , resulting in allergen tolerance with downregulation of preexisting Th2 responses .", "label": "", "metadata": {}, "score": "56.415203"}
{"text": "These studies reaffirm that an effective and safe dosing regimen will need to be established for each allergen extract formulation .Induction schedule .In contrast to SCIT , accelerated induction schedules with SLIT do not appear to be associated with a greater risk of systemic reaction .", "label": "", "metadata": {}, "score": "56.46914"}
{"text": "This approach allows the local allergy burden to be determined at different centers and seems applicable for prospective and retrospective studies , but its use remains to be validated .", "label": "", "metadata": {}, "score": "56.49927"}
{"text": "Following the pioneer studies by Noon and Freeman [ 1 , 2 ] conducted a century ago , allergen - specific immunotherapy is presently the only curative treatment for type I allergies .", "label": "", "metadata": {}, "score": "56.61633"}
{"text": "10 , pp .5629 - 5637 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .G. Senti , B. M. Prinz Vavricka , I. Erdmann et al . , \" Intralymphatic allergen administration renders specific immunotherapy faster and safer : a randomized controlled trial , \" Proceedings of the National Academy of Sciences of the United States of America , vol .", "label": "", "metadata": {}, "score": "56.621704"}
{"text": "More data are needed to validate the efficacy of sublingual and subcutaneous multiallergen immunotherapy in clinical practice in polysensitized patients .Component - resolved diagnosis could improve the reliability of choosing particular molecular components of allergens for immunotherapy .", "label": "", "metadata": {}, "score": "56.883987"}
{"text": "Larger and more rigorous studies are needed to confirm its efficacy .Further studies are needed to evaluate SLIT for latex allergy .A recent prospective , observational , open , case - control study provided encouraging results in children [ 223 ] , but was not confirmed in a randomized double - blind placebo - controlled ( RDBPC ) trial in adults [ 224 ] .", "label": "", "metadata": {}, "score": "56.894432"}
{"text": "Combined with the low availability of assays for these markers in daily practice and anticipated high costs , these results mean that further investigation is needed to identify an ideal surrogate marker [ 259 ] .", "label": "", "metadata": {}, "score": "56.948723"}
{"text": "Similar studies for perennial allergies represent an important unmet need .Chapter 7 : Efficacy of SLIT in children .Twenty - six articles were excluded : 2 had already been included in the original WAO SLIT paper [ 124 , 125 ] , 1 was on subcutaneous immunotherapy ( SCIT ) , 1 was for a non - allergic indication , and 22 had almost exclusively adult patients .", "label": "", "metadata": {}, "score": "57.028904"}
{"text": "Another approach investigated the use of detoxified bacterial toxins or carbohydrate polymers adjuvanted to allergens as \" microparticles \" and mucoadhesive particles [ 324 , 327 - 329 ] .", "label": "", "metadata": {}, "score": "57.06642"}
{"text": "In addition , this analysis did not include the most recent large trials .However , the increasing number of available studies has enabled more detailed meta - analyses , for instance according to the allergen or the disease .", "label": "", "metadata": {}, "score": "57.12361"}
{"text": "Howarth P , Malling HJ , Molimard M , Devillier P : Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients .", "label": "", "metadata": {}, "score": "57.22651"}
{"text": "One pending question regarding the use of recombinant allergens for immunotherapy is whether IgE binding epitopes should be preserved in the molecule [ 53 ] .", "label": "", "metadata": {}, "score": "57.273064"}
{"text": "Depigmented - polymerised allergen extracts appear to favour Treg expansion over activation of effector T cells to a greater extent than unmodified allergen extracts . 1\u03b1 , 25-dihydroxyvitamin D3 further reduces effector T cell activation by both allergen extracts , and may be a useful adjuvant for SIT .", "label": "", "metadata": {}, "score": "57.303577"}
{"text": "High - dose grass pollen SLIT has been shown to have a sustained effect [ 3 , 260 ] , and 3 years of treatment provides a beneficial effect that lasts for a further 2 years after stopping treatment [ 4 , 120 , 261 ] .", "label": "", "metadata": {}, "score": "57.348583"}
{"text": "In order to improve efficacy , reduce dosing and improve safety of allergen immunotherapy a number of adjuvants have been examined .In particular , there is much current interest in 1\u03b1 , 25-dihydroxyvitamin D3 , which can expand both induced IL-10-producing and Foxp3 + Treg in vitro , and improved effects of immunotherapy in animal models [ 18 - 21 ] .", "label": "", "metadata": {}, "score": "57.421967"}
{"text": "PubMed View Article .Didier A , Malling HJ , Worm M , Horak F , J\u00e4ger S , Montagut A , Andr\u00e9 C , de Beaumont O , Melac M : Optimal dose , efficacy , and safety of once - daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "57.457222"}
{"text": "10.1016/0091 - 6749(85)90661-X. PubMed View Article .Casanovas M , G\u00f3mez MJ , Carn\u00e9s J , Fern\u00e1ndez - Caldas E : Skin tests with native , depigmented and glutaraldehyde polymerized allergen extracts .", "label": "", "metadata": {}, "score": "57.50112"}
{"text": "These data support that Tregs are induced early , followed by delayed immune deviation in favor of Th1 responses at 12 months .Several other recent studies support these observations [ 23 - 27 ] .", "label": "", "metadata": {}, "score": "57.54051"}
{"text": "Halken et al .[129 ] showed that the 5-grass tablet was just as effective in school children ( 5 - 11 y ) as in adolescents ( 12 - 17 y ) , and there was enhanced efficacy during the peak pollen season .", "label": "", "metadata": {}, "score": "57.581844"}
{"text": "Further studies are required to examine the effects of Depig - pol extracts on Tregs in vivo , and to determine whether 1\u03b1 , 25-dihydroxyvitamin D3 can enhance tolerance in a clinical setting of SIT .", "label": "", "metadata": {}, "score": "57.61233"}
{"text": "In addition , the potency of some European allergen extracts differs markedly from standardized allergenic extract preparations licensed in the US [ 227 ] .However , because the effectiveness of SLIT also depends on additional factors apart from the exact dose ( e.g. , qualitative composition , presence of different adjuvant molecules , bioavailability , route of administration ) , appropriate SLIT dose - finding studies should be done for each product [ 56 ] .", "label": "", "metadata": {}, "score": "57.73561"}
{"text": "638 - 645 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J.-P. Allam , N. Novak , C. Fuchs et al . , \" Characterization of dendritic cells from human oral mucosa : a new Langerhans ' cell type with high constitutive Fc \u03b5 RI expression , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "57.777653"}
{"text": "Recent attempts have been made to standardize the collection of cytokines , mediators , and antibodies in fluid collected on filters and sponges applied directly to the nasal mucosa after nasal challenge [ 19 ] .", "label": "", "metadata": {}, "score": "57.82142"}
{"text": "Pozzan M , Milani M : Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata : a randomised , assessor - blinded , patient - reported outcome , controlled 3-year trial .", "label": "", "metadata": {}, "score": "57.86909"}
{"text": "In pollen - induced allergic rhinitis , several years of subcutaneous or sublingual allergen immunotherapy are associated with sustained clinical efficacy after subsequent treatment cessation - confirming the disease - modifying nature of this therapy .", "label": "", "metadata": {}, "score": "57.963333"}
{"text": "Dosing schedules for SLIT products on the market .The SLIT products on the market are accompanied by a high variety of recommendations on when treatment should begin and schedules regarding the updosing and maintenance phases ( Table 12 ) .", "label": "", "metadata": {}, "score": "57.98036"}
{"text": "The fact that several consecutive seasons or years of AIT are recommended may have inspired the misconception that this therapy only becomes effective after several years .", "label": "", "metadata": {}, "score": "58.073418"}
{"text": "To examine effects of native and depigmented - polymerised extracts in stimulation of regulatory or effector cells we examined expression of CD25 , Foxp3 and CD127 after 7 days of culture of PBMC .", "label": "", "metadata": {}, "score": "58.142235"}
{"text": "PubMed View Article .Calderon MA , Simons FE , Malling HJ , Lockey RF , Moingeon P , Demoly P : Sublingual allergen immunotherapy : mode of action and its relationship with the safety profile .", "label": "", "metadata": {}, "score": "58.186443"}
{"text": "Counseling for adherence .As for every chronic condition , adherence to the treatment is a critical issue .Rates of adherence in individual patients are usually reported as the percentage of the prescribed doses of medication actually taken over a specified period [ 310 ] .", "label": "", "metadata": {}, "score": "58.215614"}
{"text": "The FDA has approved allergen extracts for use in traditional allergy shots .Allergists are allowed to use these same allergen extracts for \" off - label \" use .", "label": "", "metadata": {}, "score": "58.253212"}
{"text": "Penagos M , Passalacqua G , Compalati E , Baena - Cagnani CE , Orozco S , Pedroza A , Canonica GW : Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients , 3 to 18 years of age .", "label": "", "metadata": {}, "score": "58.409645"}
{"text": "Information about the dose - response effect on safety will benefit from future guidelines on the grading and reporting of adverse events , especially local reactions [ 235 ] .", "label": "", "metadata": {}, "score": "58.445045"}
{"text": "Similar safety has been reported with SLIT ultra - rush and rush induction schedules , which allow patients to achieve the target maintenance dose within minutes to hours [ 46 , 96 - 98 ] .", "label": "", "metadata": {}, "score": "58.45234"}
{"text": "Bagnasco M , Mariani G , Passalacqua G , Motta C , Bartolomei M , Falagiani P , Mistrello G , Canonica GW : Absorption and distribution kinetics of the major Parietaria judaica allergen ( Par j 1 ) administered by noninjectable routes in healthy human beings .", "label": "", "metadata": {}, "score": "58.49526"}
{"text": "PubMed View Article .Durham S , Birk AO , Andersen JS : Days with severe symptoms : an additional efficacy endpoint in immunotherapy trials .", "label": "", "metadata": {}, "score": "58.517815"}
{"text": "2006 , 61 ( Suppl 82 ) : 1 - 20 .PubMed View Article .Grammer LC , Shaughnessy MA , Patterson R : Modified forms of allergen immunotherapy .", "label": "", "metadata": {}, "score": "58.642296"}
{"text": "In parallel with these novel clinical data , there have been advances in our understanding of the underlying mechanisms of SLIT that may give rise to putative biomarkers to predict the clinical response [ 5 - 8 ] .", "label": "", "metadata": {}, "score": "58.72021"}
{"text": "In 6 case reports of SLIT - associated anaphylaxis [ 79 - 84 ] , 5 of 6 patients were female , all were adolescents or young adults , 5 of the 6 had a history of asthma , and 2 had a previous history of severe reactions to SCIT .", "label": "", "metadata": {}, "score": "58.72974"}
{"text": "Collection of nasal fluid on sponges or absorbent filters with measurement of mediators and cytokines has been validated in response to nasal provocation , but not in the context of immunotherapy trials [ 19 ] , although studies are in progress .", "label": "", "metadata": {}, "score": "58.740807"}
{"text": "Therefore , the authors concluded that SLIT can also be effective in patients with multiple sensitizations , provided that the clinically relevant allergen is correctly identified [ 68 ] .", "label": "", "metadata": {}, "score": "58.820595"}
{"text": "Unmet needs .Chapter 12 : Practical aspects of schedules and dosages and counseling for adherence .As a consequence , a comparison of the potency of different allergy immunotherapy ( AIT ) products is not feasible .", "label": "", "metadata": {}, "score": "58.836464"}
{"text": "Patients receiving immunotherapy frequently have poor knowledge and unfounded expectations of various important aspects of their treatment .However , dissemination strategies of immunotherapy have shown that appropriate knowledge is crucial for better compliance and effectiveness of immunotherapy [ 181 ] .", "label": "", "metadata": {}, "score": "58.860466"}
{"text": "Administration of the first dose in a medically supervised setting has never been a requirement in the European Union .Allergen dose , formulation , and adverse reaction rate .", "label": "", "metadata": {}, "score": "58.86998"}
{"text": "Additional open , randomized , controlled clinical trials were performed after the publication of the previous WAO position paper [ 9 ] .These studies , despite their methodological limitations , provided some interesting insights into the efficacy of SLIT .", "label": "", "metadata": {}, "score": "58.887703"}
{"text": "These can be considered the promising future of AIT that will lead to personalized allergen immunotherapy .A more successful utilization of recombinant allergens is already present in clinical practice for advanced allergy diagnosis .", "label": "", "metadata": {}, "score": "58.917236"}
{"text": "Long - term follow - up of some of the large trials indicated that the number and intensity of AEs tend to decline with additional courses of SLIT [ 3 , 72 ] .", "label": "", "metadata": {}, "score": "58.931534"}
{"text": "CHMP / EWP/18504/2006 .London ; 2008 .Hohlfeld JM , Holland - Letz T , Larbig M , Lavae - Mokhtari M , Wierenga E , Kapsenberg M , van Ree R , Krug N , Bufe A : Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions .", "label": "", "metadata": {}, "score": "58.949158"}
{"text": "The pediatric population is expected to best benefit from the preventive effects of AIT , leading to the question of when to start treatment to achieve maximum efficacy .", "label": "", "metadata": {}, "score": "58.95537"}
{"text": "In particular , myeloid DCs and stimuli that activate them broke the tolerance of allergen - specific CD4 + T cells , whereas plasmacytoid DCs and stimuli that activate them , such as TLR7 and TLR9 agonists , did not have any effect .", "label": "", "metadata": {}, "score": "58.98281"}
{"text": "VI .Specific immunotherapy prevents the onset of new sensitizations in children .Didier A , Malling HJ , Worm M , Horak F , Sussman G , Melac M , Soulie S , Zeldin RK : Post - treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen - induced allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "59.00982"}
{"text": "Provocation tests ( e.g. , conjunctival , nasal , or bronchial provocation or allergen exposure in allergen challenge chambers ) may be used as primary endpoints in early - stage , dose - ranging ( phase 2 ) studies [ 247 ] .", "label": "", "metadata": {}, "score": "59.229237"}
{"text": "PubMed View Article .Nissen SP , Kjaer HF , H\u00f8st A , Nielsen J , Halken S : The natural course of sensitization and allergic diseases from childhood to adulthood .", "label": "", "metadata": {}, "score": "59.233585"}
{"text": "This led the authors to conclude that the \" effective dose range [ for SLIT ] still is to be determined \" [ 303 ] .", "label": "", "metadata": {}, "score": "59.27775"}
{"text": "Two of the case reports of SLIT anaphylaxis involved multiallergen SLIT , and most of the SLIT studies employed single allergens .However , 2 studies specifically designed to compare the safety of single versus multiallergen SLIT in adults and children found no significant differences in terms of frequency or severity of treatment - related AEs [ 108 , 109 ] .", "label": "", "metadata": {}, "score": "59.306816"}
{"text": "Subsequent to this review , there have been a few case reports of systemic reactions of a severity that should be categorized as anaphylaxis ( Table 6 ) [ 79 - 86 ] .", "label": "", "metadata": {}, "score": "59.33131"}
{"text": "Wahn U , Klimek L , Ploszczuk A , Adelt T , Sandner B , Trebas - Pietras E , Eberle P , Bufe A : High - dose sublingual immunotherapy with single - dose aqueous grass pollen extract in children is effective and safe : a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "59.421814"}
{"text": "This review focuses on the clinical indications , mechanisms of action , and future developments pertaining to sublingual allergy vaccines .Table 1 : Compared characteristics of sublingual versus other administration routes for allergy vaccines .", "label": "", "metadata": {}, "score": "59.565487"}
{"text": "Ideally , subjects included in AIT trials should have experienced moderate to severe disease in previous years [ 215 ] .Registration studies should enroll patients who are not taking regular medications for the treatment of allergic diseases in order to assess the magnitude of the treatment effect .", "label": "", "metadata": {}, "score": "59.59354"}
{"text": "108 - 118 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .V. Lombardi , L. van Overtvelt , S. Horiot et al . , \" Toll - like receptor 2 agonist Pam3CSK4 enhances the induction of antigen - specific tolerance via the sublingual route , \" Clinical and Experimental Allergy , vol .", "label": "", "metadata": {}, "score": "59.60434"}
{"text": "Many symptoms of allergy can be managed with the judicious use of pharmacotherapy , but for some , particularly where medications are not effective or where very - long - term treatment is required , AIT offers the prospect of a cure .", "label": "", "metadata": {}, "score": "59.61045"}
{"text": "In between , the amount of major allergen in 2 liquid SLIT products was modified , and 1 grass - pollen tablet product was measured for the first time because it had not been on the market at the time of the first analysis 2 years earlier .", "label": "", "metadata": {}, "score": "59.65899"}
{"text": "However , studies with grass pollen sublingual tablets and extract solution have demonstrated comparable dose efficacy and safety [ 54 , 93 , 94 ] .", "label": "", "metadata": {}, "score": "59.71292"}
{"text": "J Allergy Clin Immunol 2009 , 124 : 471 - 477 .PubMed View Article .Eifan AO , Shamji MH , Durham SR : Long - term clinical and immunological effects of allergen immunotherapy .", "label": "", "metadata": {}, "score": "59.753334"}
{"text": "Since the publication of the first WAO SLIT Position Paper [ 9 ] , at least 5 large randomized double - blind placebo - controlled ( RDBPC ) trials that included more than 100 patients have been published [ 40 , 44 , 46 , 51 , 53 ] .", "label": "", "metadata": {}, "score": "59.802895"}
{"text": "AIT and pharmacotherapy should be evaluated in separate , specifically designed RCTs .In addition , AIT studies allow the use of rescue medication , further interfering with the assessment [ 216 ] .", "label": "", "metadata": {}, "score": "59.830658"}
{"text": "Polysensitization is not a contraindication to allergen immunotherapy .Sublingual allergen immunotherapy is safe for home administration .A recent review calculated that 1 billion doses were administered worldwide between 2000 and 2010 and found that the 11 case reports of anaphylaxis ( all non - fatal ) corresponded to non - standard practice .", "label": "", "metadata": {}, "score": "59.84658"}
{"text": "In large - scale clinical trials of grass pollen sublingual tablets , polysensitized patients benefited at least as much from allergen immunotherapy as did monosensitized patients [ 68 ] .", "label": "", "metadata": {}, "score": "59.916603"}
{"text": "Another that considered only grass allergens [ 57 ] clearly showed the superiority of SLIT over placebo for both symptoms and medications .Finally , another meta - analysis limited to conjunctivitis symptoms [ 2 ] confirmed a significant difference in favor of SLIT , with an SMD of 0.41 ( 95 % CI 0.28 to 0.53 ) and moderate heterogeneity ( I 2 : 59 % ) .", "label": "", "metadata": {}, "score": "59.92016"}
{"text": "PubMed View Article .Illi S , von Mutius E , Lau S , Niggemann B , Gr\u00fcber C , Wahn U , Multicentre Allergy Study ( MAS ) group : Perennial allergen sensitisation early in life and chronic asthma in children : a birth cohort study .", "label": "", "metadata": {}, "score": "60.0082"}
{"text": "The relatively rare and potentially inappropriate use of injectable epinephrine in these studies raises concerns about the benefits and harms of routine prescribing of injectable epinephrine , which may become standard practice if the product information for an FDA- approved SLIT formulation includes this recommendation .", "label": "", "metadata": {}, "score": "60.039417"}
{"text": "A relationship between dose and the frequency and severity of AEs has been demonstrated in some allergen dose - response studies [ 90 , 91 ] , but so far a \" maximum tolerated dose \" has not been documented for SLIT .", "label": "", "metadata": {}, "score": "60.040115"}
{"text": "The guidelines also state that AIT is particularly appropriate in patients suffering from moderate - to - severe AR in whom symptomatic treatments are inefficacious , poorly tolerated or not wanted .", "label": "", "metadata": {}, "score": "60.0559"}
{"text": "The clinical efficacy of sublingual immunotherapy ( SLIT ) with natural allergen extracts has been established in IgE - dependent respiratory allergies to grass or tree pollens , as well as house dust mites .", "label": "", "metadata": {}, "score": "60.24315"}
{"text": "Over time , the allergist will slowly increase the amount of allergens contained in the drops or tablets , until your system no longer sees these allergens as harmful .", "label": "", "metadata": {}, "score": "60.256344"}
{"text": "They are currently used in clinical practice for advanced allergy diagnosis and will possibly be used in the future for AIT .These products are not generics , but are rather defined as \" biosimilars \" .", "label": "", "metadata": {}, "score": "60.332203"}
{"text": "Amount of Phl p 5 and Bet v 1 allergens in SLIT products .The authors concluded that the Phl p 5 content in daily doses of the SLIT products ranged from 0.2 to 21.6 \u03bcg in the extracts investigated ( reviewed in [ 305 ] ; Table 10 ) .", "label": "", "metadata": {}, "score": "60.463943"}
{"text": "The efficacy of products for SLIT therefore has to be evaluated in special trials in the pediatric population and not in combined trials of children and adults or derived from extrapolations [ 247 ] .", "label": "", "metadata": {}, "score": "60.487495"}
{"text": "A first approach in this direction has been made by the CREATE project for the development of certified reference materials for allergenic products and validation of methods for their quantification , which was initiated by the EAACI in the last decade [ 226 , 228 ] .", "label": "", "metadata": {}, "score": "60.48796"}
{"text": "Under those conditions , the rBetv 1 allergen alone was as efficient as the total birch pollen extract in alleviating patients ' symptoms during the pollen season [ 55 ] .", "label": "", "metadata": {}, "score": "60.518562"}
{"text": "Rak S , Yang WH , Pedersen MR , et al .Once - daily sublingual allergen - specific immunotherapy improves quality of life in patients with grass pollen - induced allergic rhinoconjunctivitis : A double - blind , randomised study .", "label": "", "metadata": {}, "score": "60.533993"}
{"text": "Rak S , Yang WH , Pedersen MR , et al .Once - daily sublingual allergen - specific immunotherapy improves quality of life in patients with grass pollen - induced allergic rhinoconjunctivitis : A double - blind , randomised study .", "label": "", "metadata": {}, "score": "60.533993"}
{"text": "Rak S , Yang WH , Pedersen MR , et al .Once - daily sublingual allergen - specific immunotherapy improves quality of life in patients with grass pollen - induced allergic rhinoconjunctivitis : A double - blind , randomised study .", "label": "", "metadata": {}, "score": "60.533993"}
{"text": "Rak S , Yang WH , Pedersen MR , et al .Once - daily sublingual allergen - specific immunotherapy improves quality of life in patients with grass pollen - induced allergic rhinoconjunctivitis : A double - blind , randomised study .", "label": "", "metadata": {}, "score": "60.533993"}
{"text": "Rak S , Yang WH , Pedersen MR , et al .Once - daily sublingual allergen - specific immunotherapy improves quality of life in patients with grass pollen - induced allergic rhinoconjunctivitis : A double - blind , randomised study .", "label": "", "metadata": {}, "score": "60.533993"}
{"text": "The quality of the published manuscripts from clinical trials on allergen immunotherapy is not always optimal , as shown in a CONSORT analysis of publications on SCIT and SLIT trials [ 211 ] .", "label": "", "metadata": {}, "score": "60.563046"}
{"text": "Most occur within the first few days to weeks of treatment and infrequently after this initial phase .The local AEs appear to resolve without any medical interventions , such as dose adjustments or antihistamines .", "label": "", "metadata": {}, "score": "60.593735"}
{"text": "As a consequence , SLIT preparations should be studied individually in rigorous phase 2 dose - finding studies , in parallel with studies using surrogate antigen challenges in the eye and nose [ 235 ] .", "label": "", "metadata": {}, "score": "61.028625"}
{"text": "Novel adjuvants and vector systems could be considered to further improve the efficacy of sublingual allergy vaccines [ 57 ] .Those immunopotentiators could as well allow to reduce the dose of allergens or simplify immunization schemes .", "label": "", "metadata": {}, "score": "61.08258"}
{"text": "In SLIT trials , induction and maintenance schedules varied widely in dosing interval , treatment duration , and whether treatments were administered preseasonally , pre - coseasonally , or perennially .", "label": "", "metadata": {}, "score": "61.19133"}
{"text": "SLIT can be given at home , thus avoiding multiple trips to the doctor 's office for allergy shots .There are fewer side effects with SLIT when compared with traditional allergy shots ; a smaller dose of allergens can be effectively used with SLIT .", "label": "", "metadata": {}, "score": "61.271706"}
{"text": "Ant\u00fanez C , Mayorga C , Corzo JL , Jurado A , Torres MJ : Two year follow - up of immunological response in mite - allergic children treated with sublingual immunotherapy .", "label": "", "metadata": {}, "score": "61.317993"}
{"text": "Because patients self - administer SLIT at home , there is considerable saving of time , both for the patient and of the primary care team , who only have to supervise the first dose , thus improving convenience and cost effectiveness for the patient [ 194 - 197 ] .", "label": "", "metadata": {}, "score": "61.32438"}
{"text": "A joint effort between allergists , methodologists , regulators , patient groups , and the allergen manufacturers to address important research questions is desirable to obtain answers as rapidly as possible [ 215 ] .", "label": "", "metadata": {}, "score": "61.383038"}
{"text": "Although SCIT has been occasionally performed with soluble allergens , in most circumstances , subcutaneous vaccines include adjuvants such as aluminum hydroxide or calcium phosphate .", "label": "", "metadata": {}, "score": "61.451538"}
{"text": "Prior systemic reaction with SCIT was identified as a possible risk factor in 4 patients in case reports [ 79 , 85 ] .In general , patients receiving SLIT are not prescribed injectable epinephrine in the event of a rare systemic reaction .", "label": "", "metadata": {}, "score": "61.45193"}
{"text": "Keet CA , Frischmeyer - Guerrerio PA , Thyagarajan A , Schroeder JT , Hamilton RG , Boden S , Steele P , Driggers S , Burks AW , Wood RA : The safety and efficacy of sublingual and oral immunotherapy for milk allergy .", "label": "", "metadata": {}, "score": "61.580315"}
{"text": "The authors concluded that the Bet v 1 amount in the daily doses of investigated SLIT products ranged from 1.0 to 46.7 \u03bcg in the extracts investigated .", "label": "", "metadata": {}, "score": "61.58336"}
{"text": "However , there are now many meta - analyses , systematic reviews and high - quality clinical trials that find overwhelmingly in favor of the efficacy of allergen immunotherapy ( including sublingual formulations ) in allergic rhinitis induced by pollen and , increasingly , other allergens .", "label": "", "metadata": {}, "score": "61.635586"}
{"text": "The study by Eifan et al .[ 27 ] was randomized , open , and controlled and involved 48 children monosensitized to mite .They received SCIT , SLIT , or pharmacotherapy alone for 1 year .", "label": "", "metadata": {}, "score": "61.641426"}
{"text": "summarized all available information as provided by the manufacturers on the monthly maintenance doses of different SLIT products [ 303 ] .The authors reported that these doses were 5 to 45 times higher than the doses for subcutaneous immunotherapy ( SCIT ) products from the same manufacturers .", "label": "", "metadata": {}, "score": "61.725758"}
{"text": "Baseline assessment .Most large AIT RCTs require participants to have had moderate to severe symptoms in previous years .Patients ' medical allergy history data are used in most RCTs , but they may not be reliable , because patients are likely to recall the most severe symptoms but not the average symptoms from the previous season .", "label": "", "metadata": {}, "score": "61.77731"}
{"text": "Long - term studies can also be planned to document effects on the prevention of asthma and the spread of sensitization .Studies intended to address more than one claim must be carefully preplanned to avoid methodological problems .", "label": "", "metadata": {}, "score": "61.778175"}
{"text": "The IgE response to an antigenically complex whole allergen extract includes antibodies to irrelevant molecules and to highly cross - reactive allergens .IgE epitopes may be limited to some allergenic molecules by abundance and perhaps solubility , and may also be affected by the potentially large variability between preparations of crude extracts .", "label": "", "metadata": {}, "score": "61.978416"}
{"text": "Kulis M , Saba K , Kim EH , Bird JA , Kamilaris N , Vickery BP , Staats H , Burks AW : Increased peanut - specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy .", "label": "", "metadata": {}, "score": "62.024673"}
{"text": "In general , AIT has been studied in adults and children without any significant concomitant chronic illness , and no controlled studies have evaluated effectiveness or risks associated with immunotherapy in patients with immunodeficiency or autoimmune disorders .", "label": "", "metadata": {}, "score": "62.0632"}
{"text": "The clinical relevance of this enhancement of specific antibody responses remains to be established .Mucosal vectors could also enhance SLIT efficacy , for example , by protecting the allergen(s ) from degradation by local proteases or by targeting the allergen to antigen - presenting cells [ 57 ] .", "label": "", "metadata": {}, "score": "62.284443"}
{"text": "A recent document , produced by a Task Force of the EAACI Immunotherapy Interest Group , evaluated the currently available data on dose - response relationships in AIT and provided recommendations for the design of future studies [ 56 ] .", "label": "", "metadata": {}, "score": "62.375347"}
{"text": "These are currently managed suboptimally in the community setting [ 145 , 146 ] , and because of their relative scarcity , allergy specialists are often difficult to access .", "label": "", "metadata": {}, "score": "62.43749"}
{"text": "Description of the local side effects related to SLIT ( MedDRA 14.1 ) [ 78 ] .SLIT serious adverse events .In the SLIT comprehensive review [ 69 ] , there were no fatalities or SLIT - related systemic reactions associated with hypotension , although there were 14 probable SLIT - related SAEs in 3984 patients treated with a total of 1,019,826 doses .", "label": "", "metadata": {}, "score": "62.462296"}
{"text": "Gastaminza G , Algorta J , Uriel O , Audicana MT , Fernandez E , Sanz ML , Munoz D : Randomized , double - blind , placebo - controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients .", "label": "", "metadata": {}, "score": "62.543167"}
{"text": "Vita and co - workers reported a relationship between the number of follow - up visits and the adherence to treatment [ 270 ] .In fact , the number of patients who withdrew from treatment was significantly lower in the group of patients who received 3 visits / year than in the group of patients who were seen at longer intervals .", "label": "", "metadata": {}, "score": "62.685753"}
{"text": "Because this is a tool for evaluating published data , it does not necessarily indicate poor quality of the trials themselves , but it does demonstrate that there is a need for improved quality of published documents .", "label": "", "metadata": {}, "score": "62.738426"}
{"text": "[139 ] reported that IgE sensitization profiles to P. pratense are highly heterogeneous .When molecularly designed SLIT preparations are tailored to patients ' needs , this high heterogeneity should be taken into consideration and formulations should be driven by the allergens identified in locally performed population studies .", "label": "", "metadata": {}, "score": "62.744675"}
{"text": "However , our recent data shows that 1\u03b1 , 25-dihydroxyvitamin D3 can also expand Foxp3 hi Tregs [ 20 ] .The type of Treg emerging depended on the concentration of 1\u03b1 , 25-dihydroxyvitamin D3 in cultures , and the cytokine milieu and essentially no co - expression of Foxp3 and IL-10 was observed , although both populations exhibited comparable suppressive activity [ 19 , 20 ] .", "label": "", "metadata": {}, "score": "62.788948"}
{"text": "Allergen immunotherapy is not necessarily suitable for all allergic rhinitis patients ( notably those with mild symptoms ) .Recent evidence from double - blind , placebo - controlled , randomized clinical trials suggests that the more severe the disease , the greater the treatment effect .", "label": "", "metadata": {}, "score": "62.80967"}
{"text": "Catherine M Hawrylowicz and Douglas S Robinson contributed equally to this work .Background .Specific allergen immunotherapy ( SIT ) is recommended for persistent allergic rhinoconjunctivitis and asthma resistant to pharmacotherapy , and is the only disease - modifying treatment in that benefit persists after stopping treatment [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "62.817497"}
{"text": "In the previous WAO SLIT position paper [ 9 ] , preliminary data were presented supporting the long - term benefits of SLIT , largely from small and/or non - randomized controlled trials .", "label": "", "metadata": {}, "score": "63.077477"}
{"text": "The cost - effectiveness of immunotherapy depends on the duration of the clinical benefit of immunotherapy following treatment cessation and on the break - even point of cumulative costs between immunotherapy and pharmacotherapy [ 273 ] .", "label": "", "metadata": {}, "score": "63.106552"}
{"text": "Therefore , immunotherapy is currently the only medical intervention that could potentially alter the natural course of allergic diseases .Better - standardized extracts and improved techniques and routes of administration , like the introduction of sublingual immunotherapy ( SLIT ) , have further enhanced the use of this treatment strategy .", "label": "", "metadata": {}, "score": "63.17796"}
{"text": "Durham SR , Yang WH , Pedersen MR , et al .Sublingual immunotherapy with once - daily grass allergen tablets : a randomized controlled trial in seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "63.22797"}
{"text": "Durham SR , Yang WH , Pedersen MR , et al .Sublingual immunotherapy with once - daily grass allergen tablets : a randomized controlled trial in seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "63.22797"}
{"text": "Durham SR , Yang WH , Pedersen MR , et al .Sublingual immunotherapy with once - daily grass allergen tablets : a randomized controlled trial in seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "63.22797"}
{"text": "Durham SR , Yang WH , Pedersen MR , et al .Sublingual immunotherapy with once - daily grass allergen tablets : a randomized controlled trial in seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "63.22797"}
{"text": "Durham SR , Yang WH , Pedersen MR , et al .Sublingual immunotherapy with once - daily grass allergen tablets : a randomized controlled trial in seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "63.22797"}
{"text": "Cox LS , Casale TB , Nayak AS , Bernstein DI , Creticos PS , Ambroisine L , Melac M , Zeldin RK : Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study : the importance of allergen - specific serum IgE. Creticos PS , Maloney J , Bernstein DI , Casale T , Kaur A , Fisher R , Liu N , Murphy K , Nekam K , Nolte H : Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults .", "label": "", "metadata": {}, "score": "63.27551"}
{"text": "Carbamylated allergoids have the advantage of reduced IgE - binding activity , which improves the safety profile , and enhanced bioavailability , as observed in pharmacokinetic studies [ 333 ] .", "label": "", "metadata": {}, "score": "63.357162"}
{"text": "In a Danish survey , 83 % of patients with moderate - to - severe rhinitis were undertreated ( that is , they were receiving antihistamines only or even no treatment at all ) [ 8 ] .", "label": "", "metadata": {}, "score": "63.441864"}
{"text": "Nonetheless , these reports have an inherent limitation in that the observation itself can distort the results to some extent .Sales data provided by manufacturers show an alarming rate of SLIT discontinuation , approximately 90 % at 3 years after the prescription is first written [ 263 ] .", "label": "", "metadata": {}, "score": "63.457245"}
{"text": "Smith H , White P , Annila I , et al .Randomized controlled trial of high - dose sublingual immunotherapy to treat seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "63.4851"}
{"text": "Smith H , White P , Annila I , et al .Randomized controlled trial of high - dose sublingual immunotherapy to treat seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "63.4851"}
{"text": "Smith H , White P , Annila I , et al .Randomized controlled trial of high - dose sublingual immunotherapy to treat seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "63.4851"}
{"text": "Smith H , White P , Annila I , et al .Randomized controlled trial of high - dose sublingual immunotherapy to treat seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "63.4851"}
{"text": "Smith H , White P , Annila I , et al .Randomized controlled trial of high - dose sublingual immunotherapy to treat seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "63.4851"}
{"text": "Further and more prolonged studies are required to confirm or exclude whether tetramer tracking of T cells is valuable as a biomarker of early onset of SLIT efficacy .", "label": "", "metadata": {}, "score": "63.510185"}
{"text": "249 - 260 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. B. Pajno , L. Morabito , G. Barberio , and S. Parmiani , \" Clinical and immunologic effects of long - term sublingual immunotherapy in asthmatic children sensitized to mites : a double - blind , placebo - controlled study , \" Allergy , vol .", "label": "", "metadata": {}, "score": "63.63554"}
{"text": "The recent evolution of ' definitive , ' adequately powered , multicenter randomized controlled trials in both children and adults should minimize these concerns .Furthermore , both the European and American Academies of Allergy , Asthma , and Immunology have established surveillance studies of AIT to be completed by their members [ 71 , 301 ] .", "label": "", "metadata": {}, "score": "63.641083"}
{"text": "PubMed PubMed Central .Chambers ES , Nanzer AM , Richards DF , Ryanna K , Freeman AT , Timms PM , Martineau AR , Griffiths CJ , Corrigan CJ , Hawrylowicz CM : Serum 25-dihydroxyvitamin D levels correlate with CD4 ( + ) Foxp3 ( + ) T - cell numbers in moderate / severe asthma .", "label": "", "metadata": {}, "score": "63.657547"}
{"text": "The following can contribute to increasing awareness of AIT : .Proper documentation and instructions from the prescribing allergist 's office as well as forms designed for complete and accurate documentation of therapy are vital components of safe administration .", "label": "", "metadata": {}, "score": "63.741318"}
{"text": "Table 7 .Long - term efficacy of sublingual immunotherapy after discontinuation of treatment .In this study , 810 children aged 5 - 12 years who have grass pollen rhinoconjunctivitis will receive sublingual single - grass pollen extract allergy immunotherapy tablets daily for 3 years , followed by 2 years of continued blinded follow up .", "label": "", "metadata": {}, "score": "63.79251"}
{"text": "Older studies often used the total symptom score and the total medication score individually for the primary efficacy analysis .Because the intake of rescue medication interferes with the assessment of symptom scores , the Committee for Medicinal Products for Human Use of the European Medicines Agency ( EMA ) has recommended the use of combined symptom - medication scores but has not specified a recommended instrument [ 247 ] .", "label": "", "metadata": {}, "score": "63.82405"}
{"text": "ZLU , DR and CB performed all experiments .MEM measured serum allergen specific IgE and with JC supervised preparation of extracts .ZLU , DFR , DSR and CMH analysed data and ZLU , DSR and CMH wrote the manuscript .", "label": "", "metadata": {}, "score": "63.922535"}
{"text": "A validated clinical minimal difference of the primary outcome parameters in RCTs is still an unmet need [ 215 ] .The decrease in symptom scores should be high enough to clearly reduce allergy - related morbidity under \" real life \" conditions [ 215 ] .", "label": "", "metadata": {}, "score": "63.93856"}
{"text": "The Task Force examined the clinical trials and the postmarketing surveillance data , and considered the MedDRA nomenclature [ 77 ] ( Table 4 ) in the development of the clinically based 3-grade classification system for local SLIT reactions ( Table 5 ) .", "label": "", "metadata": {}, "score": "64.038605"}
{"text": "For example , one study of dust mite - allergic asthmatic children that employed a relatively low - dose dust mite SLIT ( 15 mcg cumulative monthly dose [ CMD ] of Der p 1 ) reported a systemic reaction rate of 0.46 % per dose [ 88 ] .", "label": "", "metadata": {}, "score": "64.072845"}
{"text": "Marogna M , Tomassetti D , Bernasconi A , et al .Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study .", "label": "", "metadata": {}, "score": "64.089035"}
{"text": "Marogna M , Tomassetti D , Bernasconi A , et al .Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study .", "label": "", "metadata": {}, "score": "64.08905"}
{"text": "Marogna M , Tomassetti D , Bernasconi A , et al .Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study .", "label": "", "metadata": {}, "score": "64.08905"}
{"text": "Marogna M , Tomassetti D , Bernasconi A , et al .Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study .", "label": "", "metadata": {}, "score": "64.08905"}
{"text": "Marogna M , Tomassetti D , Bernasconi A , et al .Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study .", "label": "", "metadata": {}, "score": "64.08905"}
{"text": "A predictive biomarker might aid in selecting patients who will respond ( or in excluding potential nonresponders ) , whereas a surrogate biomarker might be effective in monitoring the clinical response to treatment .", "label": "", "metadata": {}, "score": "64.09398"}
{"text": "Cadario G , Galluccio AG , Pezza M , Appino A , Milani M , Pecora S , Mastrandrea F : Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity : a prospective pilot study .", "label": "", "metadata": {}, "score": "64.10921"}
{"text": "The second study [ 24 ] was a double - blind , double - dummy , 4-parallel - group trial to assess the efficacy and feasibility of SCIT induction followed by SLIT maintenance .", "label": "", "metadata": {}, "score": "64.192764"}
{"text": "The Federal Drug Administration ( FDA ) has stipulated a similar requirement for prescribing epinephrine autoinjectors for the subjects participating in US SLIT clinical trials .", "label": "", "metadata": {}, "score": "64.23978"}
{"text": "Saint - Lu N , Tourdot S , Razafindratsita A , Mascarell L , Berjont N , Chabre H , Louise A , Van Overtvelt L , Moingeon P : Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction .", "label": "", "metadata": {}, "score": "64.243614"}
{"text": "However , the great heterogeneity of the results ( due to the inherent heterogeneity of trials ) still limits the reliability of the results [ 60 , 61 ] .", "label": "", "metadata": {}, "score": "64.25319"}
{"text": "View Article .Kahlert H , Grage - Griebenow E , St\u00fcwe HT , Cromwell O , Fiebig H : T cell reactivity with allergoids : influence of the type of APC .", "label": "", "metadata": {}, "score": "64.27939"}
{"text": "Addition of 1\u03b1 , 25-dihydroxyvitamin D3 to cultures further favours CD25 hi Foxp3 hi CD127 lo T cells .Thus the ratio of regulatory to effector cells after cultures was further increased by addition of 1\u03b1 , 25-dihydroxyvitamin D3 ( Figure 4 B ) .", "label": "", "metadata": {}, "score": "64.3118"}
{"text": "Oral dendritic cells may be the ideal target cells for adjuvanted SLIT , which could enhance the tolerance mediated by these cells and mimic the natural contact of the individual 's immune system to allergens [ 324 ] .", "label": "", "metadata": {}, "score": "64.3463"}
{"text": "Maximal proliferation was seen at day 7 for all extracts except for Depig - pol HDM extract which was highest at day 9 ( Figure 1 A ) .", "label": "", "metadata": {}, "score": "64.397675"}
{"text": "Improvement of adherence is likely to be achieved by improving the patient information provided by prescribers [ 266 , 268 , 269 ] and reducing the interval between follow - up visits [ 269 , 270 ] .", "label": "", "metadata": {}, "score": "64.479034"}
{"text": "Currently , sublingual vaccines are based on aqueous extracts prepared from natural allergenic materials such as animal hair , pollens , or lab cultures of house dust mites [ 22 ] .", "label": "", "metadata": {}, "score": "64.49625"}
{"text": "Passalacqua G , Guerra L , Fumagalli F , et al .Safety profile of sublingual immunotherapy .Treat Respir Med .Kleine - Tebbe J , Ribel M , Herold DA .", "label": "", "metadata": {}, "score": "64.505875"}
{"text": "Passalacqua G , Guerra L , Fumagalli F , et al .Safety profile of sublingual immunotherapy .Treat Respir Med .Kleine - Tebbe J , Ribel M , Herold DA .", "label": "", "metadata": {}, "score": "64.505875"}
{"text": "Passalacqua G , Guerra L , Fumagalli F , et al .Safety profile of sublingual immunotherapy .Treat Respir Med .Kleine - Tebbe J , Ribel M , Herold DA .", "label": "", "metadata": {}, "score": "64.505875"}
{"text": "Passalacqua G , Guerra L , Fumagalli F , et al .Safety profile of sublingual immunotherapy .Treat Respir Med .Kleine - Tebbe J , Ribel M , Herold DA .", "label": "", "metadata": {}, "score": "64.505875"}
{"text": "Passalacqua G , Guerra L , Fumagalli F , et al .Safety profile of sublingual immunotherapy .Treat Respir Med .Kleine - Tebbe J , Ribel M , Herold DA .", "label": "", "metadata": {}, "score": "64.505875"}
{"text": "PubMed View Article .Nelson H , Blaiss M , Nolte H , W\u00fcrtz SO , Andersen JS , Durham SR : Efficacy and safety of the SQ - standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects .", "label": "", "metadata": {}, "score": "64.705215"}
{"text": "B Dose - response for proliferation of Depig - pol , and native HDM extract - stimulated PBMC at day 7 .Proliferation for depigmented HDM and GRASS extracts was very similar to that seen for native extracts , but proliferation was signficantly less for Depig - pol extracts of both HDM and GRASS when compared to native unmodified extracts ( Figure 1 B and ref [ 7 ] ) .", "label": "", "metadata": {}, "score": "64.74855"}
{"text": "Conclusions and future needs .Since the publication of the original WAO SLIT paper [ 9 ] , several new guidelines that focus on allergen immunotherapy have been published , as have guidelines that include statements concerning allergen immunotherapy .", "label": "", "metadata": {}, "score": "64.76277"}
{"text": "Allergen challenge chambers provide a promising tool for evaluating the therapeutic effects of AIT .This technique has been largely used in studies with drugs , and single challenge tests can not imitate the priming effect of repeated or continuous allergen exposures seen in real life , which are needed to test AIT .", "label": "", "metadata": {}, "score": "64.78751"}
{"text": "All included papers were evaluated with the GRADE system on the quality of scientific evidence from 4 ( high ) to 1 ( very low ) , as described [ 126 ] .", "label": "", "metadata": {}, "score": "64.86041"}
{"text": "Ozdemir C , Yazi D , Gocmen I , Yesil O , Aydogan M , Semic - Jusufagic A , Bahceciler NN , Barlan IB : Efficacy of long - term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite - allergic children with asthma .", "label": "", "metadata": {}, "score": "64.87839"}
{"text": "You may still need to take allergy and asthma medicine , but you may be able to take less of these medications to keep your allergies and asthma under control .", "label": "", "metadata": {}, "score": "64.90842"}
{"text": "Marogna M , Bruno M , Massolo A , Falagiani P : Long - lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity : a long - term ( 13-year ) retrospective study in real life .", "label": "", "metadata": {}, "score": "65.01575"}
{"text": "Double - blind , randomized , placebo - controlled trials .The previous World Allergy Organization ( WAO ) Position Paper [ 9 ] included 60 RDBPCs trials conducted with SLIT .", "label": "", "metadata": {}, "score": "65.18026"}
{"text": "Tonsil - derived plasmacytoid dendritic cells ( DCs ) were shown to have the ability to generate functional CD4 + CD25 + CD127 - FOXP3 + Treg cells .", "label": "", "metadata": {}, "score": "65.24022"}
{"text": "In 24 women , SLIT was initiated for the first time during pregnancy .Although these studies are reassuring in terms of the safety of SLIT during pregnancy , the numbers are small and the risks and benefits should be considered on an individual basis .", "label": "", "metadata": {}, "score": "65.2838"}
{"text": "In press .R. J. J. van Neerven , T. Wikborg , G. Lund et al . , \" Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4 + T cells by inhibiting serum - IgE - facilitated allergen presentation , \" Journal of Immunology , vol .", "label": "", "metadata": {}, "score": "65.29401"}
{"text": "The preventive benefits of AIT may be greater if initiated early in the course of the allergic disease [ 103 ] .Observational and postmarketing survey studies specifically designed to evaluate the safety of SLIT in young children found that most reactions were mild or moderate and resolved without treatment [ 104 - 106 ] .", "label": "", "metadata": {}, "score": "65.34854"}
{"text": "We have previously used this gating strategy to identify regulatory T cells after culture , and confirmed suppressive activity of these cells by re - culture of sorted cells [ 19 ] .", "label": "", "metadata": {}, "score": "65.370415"}
{"text": "A uniform definition of severe allergic diseases is expected to help in clinical practice , research and epidemiology , public health , education , registration of medicines and reimbursement , personalized medicine , and the development of novel therapies [ 234 ] .", "label": "", "metadata": {}, "score": "65.37584"}
{"text": "As a result , allergen immunotherapy for AR has long suffered from the persistence of ' false beliefs ' driven by poor methodology .Despite being a guidelines - recommended treatment , AIT is often not considered by the physician .", "label": "", "metadata": {}, "score": "65.44234"}
{"text": "Selection of patients .There is a general perception of somewhat lower efficacy results for AIT therapies compared with symptomatic therapies , owing to some confounding factors such as the inclusion of highly symptomatic patients and the allowed use of reliever medications in AIT studies .", "label": "", "metadata": {}, "score": "65.47397"}
{"text": "Tahamiler R , Saritzali G , Canakcioglu S. Long - term efficacy of sublingual immunotherapy in patients with perennial rhinitis .Laryngoscope .Calderon MA , Birk AO , Andersen JS , et al .", "label": "", "metadata": {}, "score": "65.47797"}
{"text": "Tahamiler R , Saritzali G , Canakcioglu S. Long - term efficacy of sublingual immunotherapy in patients with perennial rhinitis .Laryngoscope .Calderon MA , Birk AO , Andersen JS , et al .", "label": "", "metadata": {}, "score": "65.47797"}
{"text": "Tahamiler R , Saritzali G , Canakcioglu S. Long - term efficacy of sublingual immunotherapy in patients with perennial rhinitis .Laryngoscope .Calderon MA , Birk AO , Andersen JS , et al .", "label": "", "metadata": {}, "score": "65.47797"}
{"text": "Tahamiler R , Saritzali G , Canakcioglu S. Long - term efficacy of sublingual immunotherapy in patients with perennial rhinitis .Laryngoscope .Calderon MA , Birk AO , Andersen JS , et al .", "label": "", "metadata": {}, "score": "65.47797"}
{"text": "Tahamiler R , Saritzali G , Canakcioglu S. Long - term efficacy of sublingual immunotherapy in patients with perennial rhinitis .Laryngoscope .Calderon MA , Birk AO , Andersen JS , et al .", "label": "", "metadata": {}, "score": "65.47797"}
{"text": "Recent research has shown that both SCIT [ 173 , 174 ] and SLIT [ 175 - 180 ] are effective treatments for allergic diseases .", "label": "", "metadata": {}, "score": "65.50215"}
{"text": "PubMed View Article .Urry Z , Xystrakis E , Richards DF , McDonald J , Sattar Z , Cousins DJ , Corrigan CJ , Hickman E , Brown Z , Hawrylowicz CM : Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function .", "label": "", "metadata": {}, "score": "65.56067"}
{"text": "Even so , some US physicians do apply SLIT using the subcutaneous immunotherapy ( SCIT ) concentrated extracts to prepare the vials [ 296 - 298 ] .", "label": "", "metadata": {}, "score": "65.56642"}
{"text": "This approach would make feasible a direct comparison of different SLIT products .However , one should keep in mind that using monoclonal \" marker \" antibodies would only give information on the corresponding major allergen in SLIT preparations .", "label": "", "metadata": {}, "score": "65.58954"}
{"text": "Data suggested that SLIT could induce desensitization , but long - term studies are needed to see if tolerance will develop .Keet et al .", "label": "", "metadata": {}, "score": "65.67776"}
{"text": "For example , a study involving 257 subjects with grass pollen rhinoconjunctivitis ( who had been randomized to three years of daily treatment with grass pollen SLIT tablets or placebo ) found that clinical improvements and accompanying immunological changes were sustained for at least two years [ 20 ] .", "label": "", "metadata": {}, "score": "65.708496"}
{"text": "Studies of peripheral blood T cell phenotype , proliferation , and cytokine production following SLIT have given variable results .This is in part due to the different allergens , doses , and protocols employed for immunotherapy and the varying methods of T cell purification , processing , and storage , that are difficult to standardize in multicenter studies .", "label": "", "metadata": {}, "score": "65.735"}
{"text": "New Clinical Indications .Both subcutaneous and sublingual immunotherapies of patients with rhinoconjunctivitis appear to prevent subsequent sensitization and evolution towards asthma [ 24 , 25 , 27 , 64 ] .", "label": "", "metadata": {}, "score": "65.84839"}
{"text": "Adjuvants and modified allergens .Some SLIT preparations include adjuvants with the aim of amplifying the therapeutic effect by modulating the immune response or of further improving the safety profile .", "label": "", "metadata": {}, "score": "65.85481"}
{"text": "The CREATE project : development of certified reference materials for allergenic products and validation of methods for their quantification .Larenas - Linnemann D , Esch R , Plunkett G , Brown S , Maddox D , Barnes C , Constable D : Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units .", "label": "", "metadata": {}, "score": "65.86415"}
{"text": "Conclusions .Sublingual vaccines based on biological extracts are being used as a safe and efficacious treatment for type I respiratory allergies .To provide consistent pharmaceutical - grade products despite the inherent variability associated with biological extracts , well - established standardisation procedures and comprehensive proteomic characterization methods are being used to guarantee the quality of allergen extracts and the robustness of manufacturing processes .", "label": "", "metadata": {}, "score": "65.88924"}
{"text": "Abstract .Background .Allergen immunotherapy ( SIT ) is the only treatment for allergic disease capable of modifying disease long term .To reduce the risk of anaphylaxis from SIT , allergen - extracts have been modified by polymerisation with glutaraldehyde to reduce IgE binding .", "label": "", "metadata": {}, "score": "65.92482"}
{"text": "These data suggest reduced proliferation and cytokine production ( particularly IL-17 and IFN\u03b3 ) by PBMC from atopic donors stimulated with Depig - pol extracts compared to native , unmodified allergen extracts for grass pollen and house dust mite .", "label": "", "metadata": {}, "score": "65.92785"}
{"text": "The relative change versus placebo , when reported , ranged between 20 % and more than 35 % .Table 1 .Randomized , double - blind , placebo - controlled trials of SLIT performed since 2009 .", "label": "", "metadata": {}, "score": "66.04956"}
{"text": "An overview of the GRADE approach and grading quality of evidence about interventions .Marogna M , Massolo A , Colombo F , Isella P , Bruno M , Falagiani P : Children passive smoking jeopardises the efficacy of standard anti - allergic pharmacological therapy , while sublingual immunotherapy withstands .", "label": "", "metadata": {}, "score": "66.10725"}
{"text": "5 , pp .586 - 596 , 2010 .View at Google Scholar \u00b7 View at Scopus .P. Moingeon , V. Lombardi , N. Saint - Lu , S. Tourdot , V. Bodo , and L. Mascarell , \" Adjuvants and vector systems for allergy vaccines , \" Immunology and Allergy Clinics of North America , vol .", "label": "", "metadata": {}, "score": "66.12027"}
{"text": "The recommendation to use sublingual immunotherapy has been endorsed by the World Health Organisation ( WHO ) in several position papers on allergen immunotherapy as well as by the allergic rhinitis and its Impact on asthma ( ARIA ) workshop group [ 3 , 4 , 6 ] .", "label": "", "metadata": {}, "score": "66.12654"}
{"text": "In appropriately screened patients , modern AIT is undoubtedly safe and effective in the treatment of AR induced by common aeroallergens .Authors ' information .", "label": "", "metadata": {}, "score": "66.259476"}
{"text": "In conclusion , it seems that there is room for improving compliance by systematically addressing it and its determinants and by putting more effort into educating patients , GPs , and specialists .", "label": "", "metadata": {}, "score": "66.37018"}
{"text": "AIT : .Allergen immunotherapy .AR : .Allergic rhinitis .DBPC RCT : .Double - blind , placebo - controlled , randomized clinical trial .", "label": "", "metadata": {}, "score": "66.4073"}
{"text": "PubMed View Article .Radulovic S , Calderon MA , Wilson D , Durham S : Sublingual immunotherapy for allergic rhinitis .Cochrane Database Syst Rev 2010 .", "label": "", "metadata": {}, "score": "66.49709"}
{"text": "Effector cells in the periphery .Basophil activation can be measured ex vivo by short - term ( 1 h ) allergen stimulation of freshly harvested whole blood .", "label": "", "metadata": {}, "score": "66.54971"}
{"text": "An approach to verifying the hypothesis of positive bias due to the patients ' recognition of the active treatment would be to assess the effect of dose on the relationship between the occurrence or frequency of side effects and the observed efficacy [ 231 ] .", "label": "", "metadata": {}, "score": "66.63347"}
{"text": "Valovirta E , Myrseth SE , Palkonen S : The voice of the patients : allergic rhinitis is not a trivial disease .Curr Opin Allergy Clin Immunol 2008 , 8 : 1 - 9 .", "label": "", "metadata": {}, "score": "66.65141"}
{"text": "Marogna M , Spadolini I , Massolo A , et al .Clinical , functional , and immunologic effects of sublingual immunotherapy in birch pollinosis : a 3-year randomized controlled study .", "label": "", "metadata": {}, "score": "66.73994"}
{"text": "Marogna M , Spadolini I , Massolo A , et al .Clinical , functional , and immunologic effects of sublingual immunotherapy in birch pollinosis : a 3-year randomized controlled study .", "label": "", "metadata": {}, "score": "66.73994"}
{"text": "Marogna M , Spadolini I , Massolo A , et al .Clinical , functional , and immunologic effects of sublingual immunotherapy in birch pollinosis : a 3-year randomized controlled study .", "label": "", "metadata": {}, "score": "66.73994"}
{"text": "Marogna M , Spadolini I , Massolo A , et al .Clinical , functional , and immunologic effects of sublingual immunotherapy in birch pollinosis : a 3-year randomized controlled study .", "label": "", "metadata": {}, "score": "66.73994"}
{"text": "Marogna M , Spadolini I , Massolo A , et al .Clinical , functional , and immunologic effects of sublingual immunotherapy in birch pollinosis : a 3-year randomized controlled study .", "label": "", "metadata": {}, "score": "66.73994"}
{"text": "In contrast , less encouraging data are coming from the SLIT European market .Two recent studies showed a significant decrease of prescription renewal rates over time [ 263 , 264 ] .", "label": "", "metadata": {}, "score": "66.81103"}
{"text": "These hypotheses deserve further evaluation .Basophil activation testing is of potential value , although conflicting results have been obtained with SLIT [ 20 , 21 ] .", "label": "", "metadata": {}, "score": "66.83983"}
{"text": "The main motivations for the use of AIT were its potential effect to alter the natural course of the disease , the reduced need for anti - allergy drugs , or dissatisfaction with current pharmacotherapy .", "label": "", "metadata": {}, "score": "66.92452"}
{"text": "Data for proliferation and cytokine production was compared by ANOVA for dose response data for native and Depig - pol extracts .Values for regulatory / effector cell ratios and cytokines were compared by paired or unpaired t -test or Mann Whitney U / Wilcoxon tests as appropriate after testing for normality of distribution .", "label": "", "metadata": {}, "score": "66.987144"}
{"text": "[58 ] , which included 22 trials and a total of 979 patients .The overall results favored SLIT over placebo for rhinitis symptoms and medication scores .", "label": "", "metadata": {}, "score": "67.106125"}
{"text": "Using a different approach ( based on an analysis of the frequency of ' days with severe symptoms ' in individual patients ) , Durham et al .", "label": "", "metadata": {}, "score": "67.14375"}
{"text": "Niu CK , Chen WY , Huang JL , et al .Efficacy of sublingual immunotherapy with high - dose mite extracts in asthma : a multi - center , double - blind , randomized , and placebo - controlled study in Taiwan .", "label": "", "metadata": {}, "score": "67.17017"}
{"text": "Niu CK , Chen WY , Huang JL , et al .Efficacy of sublingual immunotherapy with high - dose mite extracts in asthma : a multi - center , double - blind , randomized , and placebo - controlled study in Taiwan .", "label": "", "metadata": {}, "score": "67.17017"}
{"text": "Niu CK , Chen WY , Huang JL , et al .Efficacy of sublingual immunotherapy with high - dose mite extracts in asthma : a multi - center , double - blind , randomized , and placebo - controlled study in Taiwan .", "label": "", "metadata": {}, "score": "67.17017"}
{"text": "Niu CK , Chen WY , Huang JL , et al .Efficacy of sublingual immunotherapy with high - dose mite extracts in asthma : a multi - center , double - blind , randomized , and placebo - controlled study in Taiwan .", "label": "", "metadata": {}, "score": "67.17017"}
{"text": "Niu CK , Chen WY , Huang JL , et al .Efficacy of sublingual immunotherapy with high - dose mite extracts in asthma : a multi - center , double - blind , randomized , and placebo - controlled study in Taiwan .", "label": "", "metadata": {}, "score": "67.17017"}
{"text": "Such IgG antibodies may act as \" blocking \" antibodies by competing with IgEs for allergen binding , thereby inhibiting IgE - mediated allergen presentation to T cells [ 44 ] .", "label": "", "metadata": {}, "score": "67.201225"}
{"text": "4 , pp .558 - 562 , 1998 .View at Google Scholar \u00b7 View at Scopus .G. Passalacqua , C. Lombardi , C. Troise , and G. W. Canonica , \" Sublingual immunotherapy : certainties , unmet needs and future directions , \" European Annals of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "67.36405"}
{"text": "Niu CK , Chen WY , Huang JL , Lue KH , Wang JY : Efficacy of sublingual immunotherapy with high - dose mite extracts in asthma : a multi - center , double - blind , randomized , and placebo - controlled study in Taiwan .", "label": "", "metadata": {}, "score": "67.4422"}
{"text": "M Calder\u00f3n declares he has received consulting fees , honoraria for lectures and/or research funding from ALK , Stallergenes , Merck , Allergopharma , HAL , and Allergy Therapeutics .", "label": "", "metadata": {}, "score": "67.49405"}
{"text": "Consistent efforts to improve the awareness among the lay public and patients at a global level will be crucial for increasing patients ' knowledge about AIT , improving their compliance , and promoting the success of this therapeutic modality .", "label": "", "metadata": {}, "score": "67.5566"}
{"text": "The parents attributed their children 's refusal to unpleasant taste .The authors speculated that the local SLIT side effects are more troublesome in young children and suggested that SLIT would best be started after age 4 because of poor adherence in younger children .", "label": "", "metadata": {}, "score": "67.671814"}
{"text": "10.1016/j.jaci.2006.07.043 .PubMed View Article .Pfaar O , Klimek L , Sager A , Br\u00e4utigam M : Safety of a depigmented , polymerized vaccine for the treatment of allergic rhinoconjunctivitis and allergic asthma .", "label": "", "metadata": {}, "score": "67.74596"}
{"text": "PubMed View Article .Frankland AW , Augustin R : Prophylaxis of summer hay - fever and asthma .Lancet 1954 , 266 : 1055 - 1057 .", "label": "", "metadata": {}, "score": "67.77952"}
{"text": "However , in view of the early onset of atopy , we consider than clinical investigations of AIT in under - fives are ethically justified .", "label": "", "metadata": {}, "score": "67.787865"}
{"text": "The study also emphasized the association between disease severity and the presence of comorbidities ( including potentially life - threatening asthma ) ; one third of the surveyed AR patients had been diagnosed with asthma and three - quarters of the asthma sufferers had moderate - to - severe AR [ 7 ] .", "label": "", "metadata": {}, "score": "67.86878"}
{"text": "1171 - 1174 , 2003 .View at Publisher \u00b7 View at Google Scholar . D. R. Wilson , A. M. Irani , S. M. Walker et al . , \" Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium , \" Clinical and Experimental Allergy , vol .", "label": "", "metadata": {}, "score": "67.87897"}
{"text": "J Allergy Clin Immunol .10.1016/S0091 - 6749(98)70271 - 4 .PubMed View Article .Alvarez - Cuesta E , Bousquet J , Canonica GW , Durham SR , Malling HJ , Valovirta E : Standards for practical allergen - specific immunotherapy .", "label": "", "metadata": {}, "score": "67.91882"}
{"text": "Allergy .Malling HJ , Lund L , Ipsen H , et al .Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets .", "label": "", "metadata": {}, "score": "67.95289"}
{"text": "Allergy .Malling HJ , Lund L , Ipsen H , et al .Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets .", "label": "", "metadata": {}, "score": "67.95289"}
{"text": "Allergy .Malling HJ , Lund L , Ipsen H , et al .Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets .", "label": "", "metadata": {}, "score": "67.95289"}
{"text": "Allergy .Malling HJ , Lund L , Ipsen H , et al .Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets .", "label": "", "metadata": {}, "score": "67.95289"}
{"text": "Allergy .Malling HJ , Lund L , Ipsen H , et al .Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets .", "label": "", "metadata": {}, "score": "67.95289"}
{"text": "10.2500/ajra.2010.24.3437 .PubMed View Article .Carn\u00e9s J , Himly M , Gallego M , Iraola V , Robinson DS , Fern\u00e1ndez - Caldas E , Briza P : Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba .", "label": "", "metadata": {}, "score": "67.99191"}
{"text": "Number of double - blind , placebo - controlled trials investigating SLIT up to June 2013 .Meta - analyses .After the previous WAO position paper [ 9 ] , 4 new meta - analyses of SLIT for respiratory allergy were published [ 2 , 57 - 59 ] .", "label": "", "metadata": {}, "score": "68.078064"}
{"text": "141 - 148 , 2003 .View at Publisher \u00b7 View at Google Scholar .J. P. Allam , G. Stojanovski , N. Friedrichs et al . , \" Distribution of Langerhans cells and mast cells within the human oral mucosa : new application sites of allergens in sublingual immunotherapy ? \"", "label": "", "metadata": {}, "score": "68.222404"}
{"text": "Food allergy .Early work in food SLIT suggests some benefit in terms of desensitization , but this has been limited to a few small trials .", "label": "", "metadata": {}, "score": "68.26642"}
{"text": "Similarly , routine medications such as antihistamines and intranasal steroids may provide adequate control of many allergic problems , such as urticaria or intermittent rhinitis .", "label": "", "metadata": {}, "score": "68.29309"}
{"text": "Adverse events , mostly local reactions , account for at least one - fourth of all dropouts in clinical trials and the rate is likely to be even higher in real - life setting [ 320 ] .", "label": "", "metadata": {}, "score": "68.376686"}
{"text": "Methodological aspects of meta - analyses .Meta - analysis is a powerful tool for evaluating the efficacy of a therapeutic intervention , and meta - analyses have clearly demonstrated that AIT is effective overall for treating allergic rhinitis and asthma [ 60 ] .", "label": "", "metadata": {}, "score": "68.38124"}
{"text": "Real - life data from the SLIT European market reveal low levels of adherence .Dosages .This makes it difficult or impossible for the prescribing allergist to compare different SLIT products with regard to the potency .", "label": "", "metadata": {}, "score": "68.489876"}
{"text": "251 - 256 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Bousquet , P. Scheinmann , M. T. Guinnepain et al . , \" Sublingual - swallow immunotherapy ( SLIT ) in patients with asthma due to house - dust mites : a double - blind , placebo - controlled study , \" Allergy , vol .", "label": "", "metadata": {}, "score": "68.539406"}
{"text": "Several large ' definitive ' trials have now confirmed the efficacy and safety for seasonal rhinitis in both children and adults .Long - term benefits of SLIT for at least 1 [ 3 ] or 2 [ 4 ] years following discontinuation of treatment have been demonstrated in 2 large independent trials of immunotherapy with grass pollen allergen tablets in adults .", "label": "", "metadata": {}, "score": "68.62654"}
{"text": "When expressed as a ratio of CD25 + Foxp3 hi CD127 lo to CD25 + Foxp3 lo CD127 + cells this was significantly higher for Depig - pol extracts of both HDM and GRASS when compared to cultures stimulated with native extracts ( Figure 3 B ) .", "label": "", "metadata": {}, "score": "68.63872"}
{"text": "Thus Depig - pol allergen extracts may favour regulatory T cells over effector T cell activation , which might be expected to augment tolerance induction in SIT .", "label": "", "metadata": {}, "score": "68.74281"}
{"text": "Sublingual immunotherapy ; Allergen - specific immunotherapy ; Mechanisms of SLIT ; Safety of SLIT ; Efficacy of SLIT ; Clinical trials methodology in SLIT .", "label": "", "metadata": {}, "score": "68.79265"}
{"text": "Such TLR ligands enhancing tolerance induction via the sublingual route share in common a capacity to elicit mixed Th1/T reg CD4 + T cell responses .", "label": "", "metadata": {}, "score": "68.83512"}
{"text": "Bernstein DI , Blaiss MS , Cox LS , Finegold I , Lanier BQ , Nelson HS , Wallace DV : Current standards and future directions in immunotherapy : perspectives on challenges and opportunities for the allergist .", "label": "", "metadata": {}, "score": "68.86904"}
{"text": "Brozek JL , Akl EA , Alonso - Coello P , Lang D , Jaeschke R , Williams JW , Phillips B , Lelgemann M , Lethaby A , Bousquet J , Guyatt GH , Schunemann HJ : Grading quality of evidence and strength of recommendations in clinical practice guidelines .", "label": "", "metadata": {}, "score": "68.87466"}
{"text": "PubMed .Pfaar O , Robinson DS , Sager A , Emuzyte R : Immunotherapy with depigmented - polymerized mixed tree pollen extract : a clinical trial and responder analysis .", "label": "", "metadata": {}, "score": "68.92374"}
{"text": "There have been no randomized , controlled , prospective studies investigating the safety of AIT during pregnancy .However , retrospective studies of women who received SCIT during pregnancy suggest that there is no greater risk of prematurity , fetal abnormality , or other adverse pregnancy outcome [ 116 , 117 ] .", "label": "", "metadata": {}, "score": "69.02577"}
{"text": "Yonekura S , Okamoto Y , Sakurai D , Horiguchi S , Hanazawa T , Nakano A , Kudou F , Nakamaru Y , Honda K , Hoshioka A , Shimojo N , Kohno Y : Sublingual immunotherapy with house dust extract for house dust - mite allergic rhinitis in children .", "label": "", "metadata": {}, "score": "69.080696"}
{"text": "4594 , pp .814 - 817 , 1911 .View at Google Scholar \u00b7 View at Scopus .J. Bousquet , R. Lockey , H. J. Malling et al . , \" Allergen immunotherapy : therapeutic vaccines for allergic diseases - a WHO position paper , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "69.21068"}
{"text": "Hoeks SB , de Groot H , Hoekstra MO .Sublingual immunotherapy in children with asthma or rhinoconjunctivitis : not enough evidence because of poor quality of the studies ; a systematic review of literature .", "label": "", "metadata": {}, "score": "69.221664"}
{"text": "Hoeks SB , de Groot H , Hoekstra MO .Sublingual immunotherapy in children with asthma or rhinoconjunctivitis : not enough evidence because of poor quality of the studies ; a systematic review of literature .", "label": "", "metadata": {}, "score": "69.221664"}
{"text": "Hoeks SB , de Groot H , Hoekstra MO .Sublingual immunotherapy in children with asthma or rhinoconjunctivitis : not enough evidence because of poor quality of the studies ; a systematic review of literature .", "label": "", "metadata": {}, "score": "69.221664"}
{"text": "Hoeks SB , de Groot H , Hoekstra MO .Sublingual immunotherapy in children with asthma or rhinoconjunctivitis : not enough evidence because of poor quality of the studies ; a systematic review of literature .", "label": "", "metadata": {}, "score": "69.221664"}
{"text": "Hoeks SB , de Groot H , Hoekstra MO .Sublingual immunotherapy in children with asthma or rhinoconjunctivitis : not enough evidence because of poor quality of the studies ; a systematic review of literature .", "label": "", "metadata": {}, "score": "69.221664"}
{"text": "Shamji MH , Ljorring C , Francis JN , Calderon MA , Larche M , Kimber I , Frew AJ , Ipsen H , Lund K , Wurtzen PA , Durham SR : Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy .", "label": "", "metadata": {}, "score": "69.290054"}
{"text": "Safety Issues .SLIT appears to be safer than conventional allergy shots .The most frequent report of adverse effects include oral itching or swelling , as well as gastrointestinal upset ; in the great majority of cases , these are mild and short - lived .", "label": "", "metadata": {}, "score": "69.292984"}
{"text": "Safety Issues .SLIT appears to be safer than conventional allergy shots .The most frequent report of adverse effects include oral itching or swelling , as well as gastrointestinal upset ; in the great majority of cases , these are mild and short - lived .", "label": "", "metadata": {}, "score": "69.292984"}
{"text": "Safety Issues .SLIT appears to be safer than conventional allergy shots .The most frequent report of adverse effects include oral itching or swelling , as well as gastrointestinal upset ; in the great majority of cases , these are mild and short - lived .", "label": "", "metadata": {}, "score": "69.292984"}
{"text": "Safety Issues .SLIT appears to be safer than conventional allergy shots .The most frequent report of adverse effects include oral itching or swelling , as well as gastrointestinal upset ; in the great majority of cases , these are mild and short - lived .", "label": "", "metadata": {}, "score": "69.292984"}
{"text": "Safety Issues .SLIT appears to be safer than conventional allergy shots .The most frequent report of adverse effects include oral itching or swelling , as well as gastrointestinal upset ; in the great majority of cases , these are mild and short - lived .", "label": "", "metadata": {}, "score": "69.292984"}
{"text": "False belief # 5 : ' There is no sustained effect after discontinuation of allergen immunotherapy ' .This misconception is hard to equate with the previous one , since AIT would then have neither short - term nor long - term efficacy .", "label": "", "metadata": {}, "score": "69.31836"}
{"text": "A recombinant form of Bet v 1 ( isoform a ) has been produced in Escherichia coli and shown to be folded similarly to the native protein , with a compact and stable structure and a well - preserved antigenicity [ 54 ] .", "label": "", "metadata": {}, "score": "69.420815"}
{"text": "Rodriguez - Perez N , Ambriz - Moreno Mde J , Canonica GW , et al .Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy .", "label": "", "metadata": {}, "score": "69.46273"}
{"text": "Rodriguez - Perez N , Ambriz - Moreno Mde J , Canonica GW , et al .Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy .", "label": "", "metadata": {}, "score": "69.46274"}
{"text": "Rodriguez - Perez N , Ambriz - Moreno Mde J , Canonica GW , et al .Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy .", "label": "", "metadata": {}, "score": "69.46274"}
{"text": "Rodriguez - Perez N , Ambriz - Moreno Mde J , Canonica GW , et al .Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy .", "label": "", "metadata": {}, "score": "69.46274"}
{"text": "Rodriguez - Perez N , Ambriz - Moreno Mde J , Canonica GW , et al .Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy .", "label": "", "metadata": {}, "score": "69.46274"}
{"text": "10.1016/j.jaci.2012.04.022 .PubMed View Article .Eur J Immunol .10.1002/eji.201242370 .PubMed PubMed Central View Article .Taher YA , van Esch BC , Hofman GA , Henricks PA , van Oosterhout AJ : 1alpha , 25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma : role for IL-10 and TGF - beta .", "label": "", "metadata": {}, "score": "69.473335"}
{"text": "A specific property of SLIT , when compared to SCIT , is further to elicit allergen - specific IgAs , both in serum and mucosal secretions [ 43 , 46 , 47 ] .", "label": "", "metadata": {}, "score": "69.50493"}
{"text": "3,15,17 To provide benefits for grass allergy season , SLIT must begin at least 8 weeks prior to the onset of the grass allergy season ; even longer lead times produce even better results .", "label": "", "metadata": {}, "score": "69.58943"}
{"text": "3,15,17 To provide benefits for grass allergy season , SLIT must begin at least 8 weeks prior to the onset of the grass allergy season ; even longer lead times produce even better results .", "label": "", "metadata": {}, "score": "69.58943"}
{"text": "3,15,17 To provide benefits for grass allergy season , SLIT must begin at least 8 weeks prior to the onset of the grass allergy season ; even longer lead times produce even better results .", "label": "", "metadata": {}, "score": "69.58943"}
{"text": "3,15,17 To provide benefits for grass allergy season , SLIT must begin at least 8 weeks prior to the onset of the grass allergy season ; even longer lead times produce even better results .", "label": "", "metadata": {}, "score": "69.58943"}
{"text": "3,15,17 To provide benefits for grass allergy season , SLIT must begin at least 8 weeks prior to the onset of the grass allergy season ; even longer lead times produce even better results .", "label": "", "metadata": {}, "score": "69.58943"}
{"text": "Collectively , these studies suggest that multiallergen SLIT is not associated with a greater safety risk than single allergen treatment .However , questions remain as to whether multiallergen immunotherapy is effective [ 68 , 110 ] .", "label": "", "metadata": {}, "score": "69.606705"}
{"text": "As with any chronic regimen , AIT thus requires good levels of patient compliance to be efficacious .Furthermore , allergens other than grass pollen remain to be investigated in detail .", "label": "", "metadata": {}, "score": "69.6152"}
{"text": "Systematic reviews and meta - analyses continue to represent the most robust forms of scientific evidence for efficacy , but they do have limitations .For example , systematic reviews are based on clinical trials that recruit highly selected patients , so that extrapolation to the whole allergic population may not always be justified .", "label": "", "metadata": {}, "score": "69.680466"}
{"text": "In addition , most of the patients with SLIT - related SAEs or anaphylaxis had asthma ; symptomatic asthma has been identified as a risk factor for AEs with SCIT [ 70 , 87 ] .", "label": "", "metadata": {}, "score": "69.68263"}
{"text": "J Allergy Clin Immunol .Passalacqua G , Pasquali M , Ariano R , et al .Randomized double - blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites .", "label": "", "metadata": {}, "score": "69.70761"}
{"text": "J Allergy Clin Immunol .Passalacqua G , Pasquali M , Ariano R , et al .Randomized double - blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites .", "label": "", "metadata": {}, "score": "69.70761"}
{"text": "J Allergy Clin Immunol .Passalacqua G , Pasquali M , Ariano R , et al .Randomized double - blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites .", "label": "", "metadata": {}, "score": "69.70761"}
{"text": "J Allergy Clin Immunol .Passalacqua G , Pasquali M , Ariano R , et al .Randomized double - blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites .", "label": "", "metadata": {}, "score": "69.70761"}
{"text": "J Allergy Clin Immunol .Passalacqua G , Pasquali M , Ariano R , et al .Randomized double - blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites .", "label": "", "metadata": {}, "score": "69.70761"}
{"text": "Chapter 14 : Raising public awareness about sublingual immunotherapy .Allergen immunotherapy ( AIT ) is effective in alleviating allergy symptoms to a similar or even greater extent than pharmacological treatments for both asthma and allergic rhinitis ; it also has long - lasting effects that persist after the treatment is discontinued .", "label": "", "metadata": {}, "score": "69.777824"}
{"text": "A similar study was conducted by Eifan et al .[ 27 ] .In a randomized trial , they studied SLIT versus SCIT versus pharmacotherapy alone .", "label": "", "metadata": {}, "score": "69.79288"}
{"text": "Many allergies can be managed by the judicious use of medications .The importance of the PCP / GP for diagnosis and management of allergy in low- and middle - income countries has also been highlighted [ 165 ] .", "label": "", "metadata": {}, "score": "69.824"}
{"text": "842 - 849 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Enrique , F. Pineda , T. Malek et al . , \" Sublingual immunotherapy for hazelnut food allergy : a randomized , double - blind , placebo - controlled study with a standardized hazelnut extract , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "69.851135"}
{"text": "An ongoing multinational RDBPC trial in 5- to 12-year - old children was first designed to assess the preventive effect of high - dose grass SLIT on asthma development , both during treatment and after the end of treatment [ 119 ] .", "label": "", "metadata": {}, "score": "69.90111"}
{"text": "For indoor allergens , the assessments of allergen exposure by measuring major allergens in reservoir dust samples ( bed , carpet , soft furnishings , and so forth ) using monoclonal antibody - based enzyme - linked immunosorbent assays might provide levels of individual exposure [ 226 ] .", "label": "", "metadata": {}, "score": "69.93034"}
{"text": "Pfaar O , Klimek L. Efficacy and safety of specific immunotherapy with a high - dose sublingual grass pollen preparation : a double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "69.969246"}
{"text": "Pfaar O , Klimek L. Efficacy and safety of specific immunotherapy with a high - dose sublingual grass pollen preparation : a double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "69.969246"}
{"text": "Pfaar O , Klimek L. Efficacy and safety of specific immunotherapy with a high - dose sublingual grass pollen preparation : a double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "69.969246"}
{"text": "Pfaar O , Klimek L. Efficacy and safety of specific immunotherapy with a high - dose sublingual grass pollen preparation : a double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "69.969246"}
{"text": "Pfaar O , Klimek L. Efficacy and safety of specific immunotherapy with a high - dose sublingual grass pollen preparation : a double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "69.96926"}
{"text": "Roger A , Justicia JL , Navarro LA , Eseverri JL , Ferres J , Malet A , Alva V : Observational study of the safety of an ultra - rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites .", "label": "", "metadata": {}, "score": "70.01088"}
{"text": "Placebo .Appropriate placebos for SLIT are needed to preserve the blinding of studies in the absence of local side effects , and any analysis of efficacy should take into account the incidence of side effects in both the SLIT and control groups [ 215 ] .", "label": "", "metadata": {}, "score": "70.040436"}
{"text": "10.1111/j.1398 - 9995.2011.02736.x .PubMed View Article .Garcia - Robaina JC , Sanchez I , de la Torre F , Fernandez - Caldas E , Casanovas M : Successful management of mite - allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "70.086914"}
{"text": "Canonica GW , Baena - Cagnani CE , Bousquet J , Bousquet PJ , Lockey RF , Malling HJ , Passalacqua G , Potter P , Valovirta E : Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy .", "label": "", "metadata": {}, "score": "70.1015"}
{"text": "Subcutaneous allergen immunotherapy .SLIT : .Sublingual allergen immunotherapy .Declarations .Competing interests .Mois\u00e9s A. Calder\u00f3n has received consulting fees , honoraria for lectures and/or research funding from ALK , Stallergenes , Merck , Allergopharma , HAL and Allergy Therapeutics . A. William Frankland has received travel grants from Stallergenes .", "label": "", "metadata": {}, "score": "70.111435"}
{"text": "As in other areas of medicine , the quality of reporting of most immunotherapy trials is low .According to a recent review , only 4.2 % of SLIT RCTs met all the criteria of the CONSORT Statement , suggesting that the use of the CONSORT Statement should be further encouraged [ 211 ] .", "label": "", "metadata": {}, "score": "70.353836"}
{"text": "Skin prick testing and raised serum allergen - specific IgE are essential predictive biomarkers that clearly augment information obtained from the history alone .Nonetheless , these tests produce both false positive and false negative results .", "label": "", "metadata": {}, "score": "70.36148"}
{"text": "It recommends considering AIT in patients with moderate to severe intermittent or persistent allergic rhinitis and in mild ( controlled ) allergic asthma proven to be caused by a well - defined allergen ; it particularly recommends AIT in those who do not respond sufficiently to current pharmacological treatment .", "label": "", "metadata": {}, "score": "70.41785"}
{"text": "Validity of single products .Meta - analyses have confirmed the effectiveness and safety of SLIT [ 1 , 185 , 334 - 336 ] .", "label": "", "metadata": {}, "score": "70.482414"}
{"text": "Leukocyte Biology Section , MRC and Asthma UK Centre for Mechanisms of Allergic Asthma , NHLI , Imperial College London .References .Bousquet J , Lockey R , Maling HJ : Allergen immunotherapy : therapeutic vaccines for allergic diseases .", "label": "", "metadata": {}, "score": "70.536125"}
{"text": "Most particularly , sublingual immunotherapy ( SLIT ) was investigated in allergic patients almost twenty years ago and is now established as a valid noninvasive alternative to subcutaneous immunization to treat type I respiratory allergies [ 5 - 8 ] .", "label": "", "metadata": {}, "score": "70.61388"}
{"text": "Eifan AO , Akkoc T , Yildiz A , Keles S , Ozdemir C , Bahceciler NN , Barlan IB : Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic / rhinitis children sensitized to house dust mite : an open randomized controlled trial .", "label": "", "metadata": {}, "score": "70.61891"}
{"text": "Unmet needs .A number of issues regarding the use of SLIT in children remain to be resolved : .Failure of pharmacological treatment is not an essential prerequisite for the use of SLIT .", "label": "", "metadata": {}, "score": "70.62502"}
{"text": "Although Depig - pol extracts stimulated reduced effector T cell expansion and activation compared to native extracts , numbers of regulatory T cells were similar , so the ratio of regulatory to effector T cells in cultures stimulated with Depig - pol extracts was significantly higher than for native extract .", "label": "", "metadata": {}, "score": "70.67284"}
{"text": "Using individual samplers to measure pollen and evaluating the effect of AIT relative to these measurements may solve this problem [ 243 ] , although this goal will be difficult to achieve .", "label": "", "metadata": {}, "score": "70.844"}
{"text": "Several issues regarding the safety of SLIT remain unresolved : .Or do some require an updosing phase ?Chapter 6 : Impact of sublingual immunotherapy on the natural history of respiratory allergy .", "label": "", "metadata": {}, "score": "70.85339"}
{"text": "The combined regimen did better than the 2 taken separately , with a slight advantage for SCIT alone over SLIT alone on some outcomes .The third study [ 62 ] was again a double - dummy study versus placebo in which both treatments achieved a significant clinical improvement versus baseline , with SCIT doing on average better than SLIT in the direct comparison .", "label": "", "metadata": {}, "score": "70.86571"}
{"text": "Further evaluation of C1Q and STAB1 expression as candidate biomarkers during large trials of sublingual allergen immunotherapy are justified .Biomarkers of clinical response to immunotherapy .", "label": "", "metadata": {}, "score": "70.97487"}
{"text": "However , the immunological efficacy of SIT most likely relates to induction of tolerance to allergens through interactions with regulatory T cells ( Treg ) [", "label": "", "metadata": {}, "score": "70.99951"}
{"text": "Some scientists have called for AIT clinical trial publications to specify the specific brand name of the immunotherapy product used [ 337 ] for both positive and negative results .", "label": "", "metadata": {}, "score": "71.0333"}
{"text": "The oral cavity is a naturally tolerogenic environment , remaining noninflamed despite being exposed continuously to multiple foreign proteins .The presence of Langerhans cells and monocytes capable of producing IL-10 and TGF - \u03b2 are major contributors to the maintenance of tolerance ( see Chapter 3 of the 2009 WAO position paper [ 9 ] ) .", "label": "", "metadata": {}, "score": "71.10395"}
{"text": "4 , pp .855 - 866 , 1991 .View at Google Scholar \u00b7 View at Scopus .G. Ciprandi , D. Fenoglio , I. Cirillo et al . , \" Induction of interleukin 10 by sublingual immunotherapy for house dust mites : a preliminary report , \" Annals of Allergy , Asthma and Immunology , vol .", "label": "", "metadata": {}, "score": "71.10608"}
{"text": "The problem of unblinding of subjects due to side effects was raised to argue against the efficacy of SLIT observed in recently concluded large clinical trials [ 229 ] .", "label": "", "metadata": {}, "score": "71.20323"}
{"text": "Wilson DR , Lima MT , Durham SR .Sublingual immunotherapy for allergic rhinitis : systematic review and meta - analysis .Allergy .Cox LS , Linnemann DL , Nolte H , et al .", "label": "", "metadata": {}, "score": "71.30572"}
{"text": "Wilson DR , Lima MT , Durham SR .Sublingual immunotherapy for allergic rhinitis : systematic review and meta - analysis .Allergy .Cox LS , Linnemann DL , Nolte H , et al .", "label": "", "metadata": {}, "score": "71.30572"}
{"text": "Wilson DR , Lima MT , Durham SR .Sublingual immunotherapy for allergic rhinitis : systematic review and meta - analysis .Allergy .Cox LS , Linnemann DL , Nolte H , et al .", "label": "", "metadata": {}, "score": "71.30572"}
{"text": "Wilson DR , Lima MT , Durham SR .Sublingual immunotherapy for allergic rhinitis : systematic review and meta - analysis .Allergy .Cox LS , Linnemann DL , Nolte H , et al .", "label": "", "metadata": {}, "score": "71.30572"}
{"text": "Wilson DR , Lima MT , Durham SR .Sublingual immunotherapy for allergic rhinitis : systematic review and meta - analysis .Allergy .Cox LS , Linnemann DL , Nolte H , et al .", "label": "", "metadata": {}, "score": "71.30572"}
{"text": "The SCIT versus SLIT results of the HDM trial by Yukselen et al .[ 62 ] are discussed in more detail in the next section .", "label": "", "metadata": {}, "score": "71.37342"}
{"text": "Calderon MA , Casale TB , Togias A , Bousquet J , Durham SR , Demoly P : Allergen - specific immunotherapy for respiratory allergies : from meta - analysis to registration and beyond .", "label": "", "metadata": {}, "score": "71.483185"}
{"text": "Potter PC , Warner JO , Pawankar R , Kaliner MA , Del Giacco S , Rosenwasser L : Recommendations for competency in allergy training for undergraduates qualifying as medical practitioners : a position paper of the World Allergy Organization .", "label": "", "metadata": {}, "score": "71.5247"}
{"text": "Representatives from the Member Societies of the World Allergy Organization reviewed and commented on the document in development .The World Allergy Organization Board of Directors approved the document .", "label": "", "metadata": {}, "score": "71.71997"}
{"text": "PubMed View Article .Kalinski P , Lebre MC , Kramer D , De Jong EC , Van Schijndel JW , Kapsenberg ML : Analysis of the CD4 + T cell responses to house dust mite allergoid .", "label": "", "metadata": {}, "score": "71.7334"}
{"text": "Depigmented - polymerised allergen extracts stimulate less T cell proliferation than native extracts , but similar cytokine production .Production of depigmented - polymerised extracts involves two steps which might alter T cell reactivity ( depigmentation : acid hydrolysis then dialysis to remove low molecular weight non - allergen material , then polymerisation with glutaraldehyde ) .", "label": "", "metadata": {}, "score": "71.81444"}
{"text": "In recognition of the need for a uniform classification system for AIT adverse reactions , an international Task Force composed of members of the academic , clinical , and research allergy communities was formed .", "label": "", "metadata": {}, "score": "71.872246"}
{"text": "Competing interests .GW Canonica declares he has received consulting fees from Allergy Therapeutics , ALK , Circassia , Hal , LoFarma , and Stallergenes .", "label": "", "metadata": {}, "score": "71.879"}
{"text": "Unfortunately , as with conventional allergy shots for hay fever , it appears that if SLIT is in fact effective , it must be used for a long time for best results .", "label": "", "metadata": {}, "score": "71.93457"}
{"text": "Unfortunately , as with conventional allergy shots for hay fever , it appears that if SLIT is in fact effective , it must be used for a long time for best results .", "label": "", "metadata": {}, "score": "71.93457"}
{"text": "Unfortunately , as with conventional allergy shots for hay fever , it appears that if SLIT is in fact effective , it must be used for a long time for best results .", "label": "", "metadata": {}, "score": "71.93457"}
{"text": "Unfortunately , as with conventional allergy shots for hay fever , it appears that if SLIT is in fact effective , it must be used for a long time for best results .", "label": "", "metadata": {}, "score": "71.93457"}
{"text": "Unfortunately , as with conventional allergy shots for hay fever , it appears that if SLIT is in fact effective , it must be used for a long time for best results .", "label": "", "metadata": {}, "score": "71.93457"}
{"text": "However , additional studies are needed to validate allergen challenge chambers more thoroughly compared to natural pollen exposure [ 19 , 256 - 258 ] .", "label": "", "metadata": {}, "score": "71.95468"}
{"text": "One consideration with SLIT is that the majority of doses are administered outside of the clinic setting with no direct medical supervision , and the accuracy of the AE reporting depends on the patient 's and/or family 's recall and interpretation of the event .", "label": "", "metadata": {}, "score": "71.97714"}
{"text": "One study suggests that SLIT is not only effective for treating allergy , but may be useful in preventing the development of new allergies or mild persistent asthma in children with allergic rhinitis or intermittent asthma .", "label": "", "metadata": {}, "score": "72.06732"}
{"text": "One study suggests that SLIT is not only effective for treating allergy , but may be useful in preventing the development of new allergies or mild persistent asthma in children with allergic rhinitis or intermittent asthma .", "label": "", "metadata": {}, "score": "72.06732"}
{"text": "One study suggests that SLIT is not only effective for treating allergy , but may be useful in preventing the development of new allergies or mild persistent asthma in children with allergic rhinitis or intermittent asthma .", "label": "", "metadata": {}, "score": "72.06732"}
{"text": "One study suggests that SLIT is not only effective for treating allergy , but may be useful in preventing the development of new allergies or mild persistent asthma in children with allergic rhinitis or intermittent asthma .", "label": "", "metadata": {}, "score": "72.06732"}
{"text": "One study suggests that SLIT is not only effective for treating allergy , but may be useful in preventing the development of new allergies or mild persistent asthma in children with allergic rhinitis or intermittent asthma .", "label": "", "metadata": {}, "score": "72.06732"}
{"text": "Chapter 11 : Guideline development : from evidence - based medicine to patients ' views .Their content is briefly reviewed in this chapter .Evidence - based medicine has become an essential component in the preparation of guidelines , in that it attempts to provide a logical , transparent , and applicable framework from which the quality and relevance of clinical studies may be assessed in an unbiased manner [ 276 ] .", "label": "", "metadata": {}, "score": "72.07144"}
{"text": "Conversely , some patients will \" outgrow \" one or more of their allergies ( essentially during adolescence ) [ 26 ] .The chronology of the natural history of AR and AA raises the question of the age at which a disease - modifying treatment , such as AIT , could be introduced in atopic children [ 27 ] .", "label": "", "metadata": {}, "score": "72.0878"}
{"text": "Here , we briefly review a number of persistent misconceptions and cite some of the robust medical and scientific evidence that should lay these false beliefs to rest at last .", "label": "", "metadata": {}, "score": "72.08853"}
{"text": "PubMed View Article .Dahl R , Kapp A , Colombo G , de Monchy JG , Rak S , Emminger W , Rivas MF , Ribel M , Durham SR : Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "72.123764"}
{"text": "PubMed View Article .Malling HJ , Montagut A , Melac M , Patriarca G , Panzner P , Seberova E , Didier A : Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "72.125885"}
{"text": "These cells comprise both suppressive as well as effector T cells , including Th1 , Th2 , and Th17 lymphocytes , likely involved in defence against infectious pathogens .", "label": "", "metadata": {}, "score": "72.16108"}
{"text": "Quality evidence from published research forms the basis of the guidelines , but safety , cost , and patients ' preferences are all considered in making the final recommendations .", "label": "", "metadata": {}, "score": "72.19922"}
{"text": "This may include seasonal airborne allergens other than plant pollens .Introduction .Quality of clinical trials .The use of appropriate methodology in randomized clinical trials ( RCTs ) is essential for the critical assessment and registration of therapeutic interventions .", "label": "", "metadata": {}, "score": "72.29776"}
{"text": "10.1111/j.1398 -9995.2010.02413.x .PubMed View Article .H\u00f6iby AS , Strand V , Robinson DS , Sager A , Rak S : Efficacy , safety , and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract : a randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "72.378395"}
{"text": "Human effector and regulatory dendritic cells are important in directing T cell differentiation , phenotype , and function .Following a detailed evaluation in vitro of human effector and regulatory dendritic cells from human monocytes cultured under deforming conditions , candidate dendritic cell markers were evaluated at the messenger RNA and protein levels before and after grass pollen allergen tablet SLIT [ 31 ] .", "label": "", "metadata": {}, "score": "72.41373"}
{"text": "This study confirms that the initial phase of SLIT with a grass pollen extract enhances sIgE synthesis and response to the same allergen components that induce IgE reactivity at natural exposure .", "label": "", "metadata": {}, "score": "72.47478"}
{"text": "With allergy shots , pollen extracts are injected under the skin , while in SLIT , they are placed under the tongue .The immune system has many components , and only one of them , the IgE / eosinophil system , produces typical allergic reactions .", "label": "", "metadata": {}, "score": "72.58897"}
{"text": "With allergy shots , pollen extracts are injected under the skin , while in SLIT , they are placed under the tongue .The immune system has many components , and only one of them , the IgE / eosinophil system , produces typical allergic reactions .", "label": "", "metadata": {}, "score": "72.58897"}
{"text": "With allergy shots , pollen extracts are injected under the skin , while in SLIT , they are placed under the tongue .The immune system has many components , and only one of them , the IgE / eosinophil system , produces typical allergic reactions .", "label": "", "metadata": {}, "score": "72.58897"}
{"text": "With allergy shots , pollen extracts are injected under the skin , while in SLIT , they are placed under the tongue .The immune system has many components , and only one of them , the IgE / eosinophil system , produces typical allergic reactions .", "label": "", "metadata": {}, "score": "72.58897"}
{"text": "With allergy shots , pollen extracts are injected under the skin , while in SLIT , they are placed under the tongue .The immune system has many components , and only one of them , the IgE / eosinophil system , produces typical allergic reactions .", "label": "", "metadata": {}, "score": "72.58897"}
{"text": "PubMed Abstract .Zuberbier T , Bachert C , Bousquet PJ , Passalacqua G , Walter Canonica G , Merk H , Worm M , Wahn U , Bousquet J : GA(2 ) LEN / EAACI pocket guide for allergen - specific immunotherapy for allergic rhinitis and asthma .", "label": "", "metadata": {}, "score": "72.703835"}
{"text": "This content is reviewed regularly and is updated when new and relevant evidence is made available .This information is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "72.75197"}
{"text": "This content is reviewed regularly and is updated when new and relevant evidence is made available .This information is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "72.75197"}
{"text": "This content is reviewed regularly and is updated when new and relevant evidence is made available .This information is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "72.75197"}
{"text": "This content is reviewed regularly and is updated when new and relevant evidence is made available .This information is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "72.75197"}
{"text": "Major problematic issues that were identified by these organizations included the following : .Strategies to increase the awareness of AIT .Efforts by patient organizations , general practitioners , non - allergist health care professionals , and pharmacists will be needed to increase the awareness of AIT among allergic patients .", "label": "", "metadata": {}, "score": "72.94085"}
{"text": "Uses .Principal Proposed Uses .Other Proposed Uses .Overview .Sublingual immunotherapy ( SLIT ) is a method of treating allergies that closely resembles conventional \" allergy shots . \" In both of these methods , small amounts of allergenic substances are administered periodically and over a long period of time , via a route different from that in which the body ordinarily encounters them .", "label": "", "metadata": {}, "score": "72.949265"}
{"text": "Chapter 9 : The future of immunotherapy in the community care setting .Emphasis should be placed on detection and management of side effects , including local and systemic reactions .", "label": "", "metadata": {}, "score": "72.99565"}
{"text": "PubMed View Article .Nolte H , Nepper - Christensen S , Backer V : Unawareness and undertreatment of asthma and allergic rhinitis in a general population .", "label": "", "metadata": {}, "score": "73.04079"}
{"text": "Modern , evidence - based medicine has generated more than enough robust evidence to remove misconceptions about allergen immunotherapy and allergic rhinitis .Keywords .Allergen Immunotherapy Specific Sublingual Subcutaneous Desensitization Vaccination .", "label": "", "metadata": {}, "score": "73.052155"}
{"text": "Principal Proposed Uses .Other Proposed Uses .Overview .Sublingual immunotherapy ( SLIT ) is a method of treating allergies that closely resembles conventional \" allergy shots . \" In both of these methods , small amounts of allergenic substances are administered periodically and over a long period of time , via a route different from that in which the body ordinarily encounters them .", "label": "", "metadata": {}, "score": "73.16458"}
{"text": "They recommend immunotherapy for allergic rhinitis , allergic conjunctivitis , and asthma as cotreatment with medication .The guidelines make a special note that SLIT is indicated in children who do not tolerate or accept injections .", "label": "", "metadata": {}, "score": "73.254074"}
{"text": "PubMed View Article .Lund L , Henmar H , W\u00fcrtzen PA , Lund G , Hjortskov N , Larsen JN : Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy .", "label": "", "metadata": {}, "score": "73.33269"}
{"text": "This article is published under license to BioMed Central Ltd. Uses .Principal Proposed Uses .Other Proposed Uses .Overview .Sublingual immunotherapy ( SLIT ) is a method of treating allergies that closely resembles conventional \" allergy shots . \" In both of these methods , small amounts of allergenic substances are administered periodically and over a long period of time , via a route different from that in which the body ordinarily encounters them .", "label": "", "metadata": {}, "score": "73.37416"}
{"text": "Other Proposed Uses .Overview .Sublingual immunotherapy ( SLIT ) is a method of treating allergies that closely resembles conventional \" allergy shots . \" In both of these methods , small amounts of allergenic substances are administered periodically and over a long period of time , via a route different from that in which the body ordinarily encounters them .", "label": "", "metadata": {}, "score": "73.50699"}
{"text": "Other Proposed Uses .Overview .Sublingual immunotherapy ( SLIT ) is a method of treating allergies that closely resembles conventional \" allergy shots . \" In both of these methods , small amounts of allergenic substances are administered periodically and over a long period of time , via a route different from that in which the body ordinarily encounters them .", "label": "", "metadata": {}, "score": "73.50699"}
{"text": "Future Directions .Development of Sublingual Recombinant Allergy Vaccines .There is , as of today , no recombinant allergy vaccine commercially available .With the advent of molecular biology and the use of recombinant DNA technology , the possibility of developing highly purified allergens for sublingual immunotherapy is raising considerable interest [ 22 , 53 ] .", "label": "", "metadata": {}, "score": "73.51203"}
{"text": "Standardized and validated primary endpoints are of paramount importance to improving the comparability of study results .In real life , patients receive both SLIT and medications to optimally control symptoms .", "label": "", "metadata": {}, "score": "73.56813"}
{"text": "Oral immunotherapy to food allergens , especially peanut allergens , is also a promising new use of this form of therapy [ 208 ] .One suggestion is to identify a subgroup of general practitioners who have a special interest in the field of allergic disease diagnosis and management .", "label": "", "metadata": {}, "score": "73.627525"}
{"text": "Factors affecting the adherence rate are important to consider .The cost is one of the most relevant , and this is clearly noticeable when comparing the sales of SLIT where the treatment is reimbursed or is paid entirely out of pocket by the patients [ 263 ] .", "label": "", "metadata": {}, "score": "73.77055"}
{"text": "Research published since 2009 has provided some interesting new insights into the effects of SLIT .Therefore , we now have medium - quality preliminary evidence of SLIT efficacy for rhinitis in children from 4 years of age [ 54 ] .", "label": "", "metadata": {}, "score": "73.80575"}
{"text": "As such , these compounds enhance SLIT efficacy in murine models of OVA - induced asthma [ 58 - 61 ] .In humans , the only adjuvant which has been tested via the sublingual route is monophosphoryl lipid A ( MPL ) , a TLR4 ligand - inducing Th1 responses .", "label": "", "metadata": {}, "score": "73.81767"}
{"text": "In the course of the past decade , new systems for guideline development and evaluation have been developed , including the Grading of Recommendations Assessment , Development , and Evaluation ( GRADE ) system [ 277 ] .", "label": "", "metadata": {}, "score": "73.88098"}
{"text": "The oral immune system comprises various antigen - presenting cells , including Langerhans cells , as well as myeloid and plasmacytoid dendritic cells ( DCs ) with a distinct localisation in the mucosa , along the lamina propria and in subepithelial tissues , respectively .", "label": "", "metadata": {}, "score": "73.905426"}
{"text": "This excellent safety profile may be due to rapidly occurring antigen capture by local , tolerogenic antigen - presenting cells and the low numbers of mast cells in sublingual tissues [ 24 ] .", "label": "", "metadata": {}, "score": "73.915634"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "73.930435"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "73.930435"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "73.930435"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "73.930435"}
{"text": "Dahl R , Kapp A , Colombo G , et al .Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "73.930435"}
{"text": "Grass pollen extract SLIT strongly improved asthma symptoms and medication scores in comparison to a blinded placebo , but the study quality was low due to a 40 % dropout rate in the placebo group [ 131 ] .", "label": "", "metadata": {}, "score": "73.94884"}
{"text": "Here , we review evidence that counters seven of these ' false beliefs . 'Discussion .The symptoms of allergic rhinitis can be more heterogeneous , more severe and more troublesome in everyday life than many physicians believe .", "label": "", "metadata": {}, "score": "73.955185"}
{"text": "Studies in Children .Because AIT has an indication for treatment of children , AIT products should be tested for efficacy and safety in pediatric populations [ 247 ] .", "label": "", "metadata": {}, "score": "73.95746"}
{"text": "Leger D , Annesi - Maesano I , Carat F , Rugina M , Chanal I , Pribil C , El Hasnaoui A , Bousquet J : Allergic rhinitis and its consequences on quality of sleep : an unexplored area .", "label": "", "metadata": {}, "score": "74.00538"}
{"text": "These misconceptions largely arose because of the empirical , poorly standardized clinical research methods that were widely used in this field until the 1950s .In a sense , Noon and Freeman were ahead of their time in describing their research so precisely and elegantly ; their reports triggered attempts by enterprising , enthusiastic physicians to administer complex therapeutics to a diverse population of patients suffering from heterogeneous medical conditions [ 3 ] .", "label": "", "metadata": {}, "score": "74.01663"}
{"text": "Calderon MA , Cox L , Casale TB , Moingeon P , Demoly P : Multiple - allergen and single - allergen immunotherapy strategies in polysensitized patients : looking at the published evidence .", "label": "", "metadata": {}, "score": "74.02422"}
{"text": "Risk factors for SLIT AEs have not been clearly established .Some studies suggest a greater frequency of AEs during the induction phase than in the maintenance phase , but there does not seem to be a relationship between induction schedule and SLIT AEs , with ultra - rush and no - induction schedules reported as being well tolerated in several studies .", "label": "", "metadata": {}, "score": "74.02972"}
{"text": "Allergy .Mosges R , Bruning H , Hessler HJ , et al .Sublingual immunotherapy in pollen - induced seasonal rhinitis and conjunctivitis : a randomized controlled trial .", "label": "", "metadata": {}, "score": "74.132515"}
{"text": "Allergy .Mosges R , Bruning H , Hessler HJ , et al .Sublingual immunotherapy in pollen - induced seasonal rhinitis and conjunctivitis : a randomized controlled trial .", "label": "", "metadata": {}, "score": "74.132515"}
{"text": "Allergy .Mosges R , Bruning H , Hessler HJ , et al .Sublingual immunotherapy in pollen - induced seasonal rhinitis and conjunctivitis : a randomized controlled trial .", "label": "", "metadata": {}, "score": "74.132515"}
{"text": "Allergy .Mosges R , Bruning H , Hessler HJ , et al .Sublingual immunotherapy in pollen - induced seasonal rhinitis and conjunctivitis : a randomized controlled trial .", "label": "", "metadata": {}, "score": "74.132515"}
{"text": "Allergy .Mosges R , Bruning H , Hessler HJ , et al .Sublingual immunotherapy in pollen - induced seasonal rhinitis and conjunctivitis : a randomized controlled trial .", "label": "", "metadata": {}, "score": "74.132515"}
{"text": "Allergen extract Depigmented - polymerised Immunotherapy Regulatory T cell Vitamin D .Electronic supplementary material .The online version of this article ( doi : 10 .", "label": "", "metadata": {}, "score": "74.17885"}
{"text": "The problem of comparing the efficacy of subcutaneous immunotherapy ( SCIT ) and SLIT is still open .The comparison is technically difficult , because head - to - head comparisons need a double - blind , double - dummy design , with a careful choice of outcomes and dosages .", "label": "", "metadata": {}, "score": "74.191956"}
{"text": "In another analysis from the German market the adherence to SLIT was even lower with only 16 % after three years of SLIT [ 316 ] .", "label": "", "metadata": {}, "score": "74.21298"}
{"text": "O'Hehir RE , Gardner LM , de Leon MP , Hales BJ , Biondo M , Douglass JA , Rolland JM , Sandrini A : House dust mite sublingual immunotherapy : the role for transforming growth factor - beta and functional regulatory T cells .", "label": "", "metadata": {}, "score": "74.275826"}
{"text": "Specific antibody levels .Studies of sublingual grass pollen immunotherapy in general show an increase in serum allergen - specific IgG4 and IgG , although the increase is not as great as that seen with SCIT [ 16 , 17 ] .", "label": "", "metadata": {}, "score": "74.35217"}
{"text": "Similarly , SLIT has been recently shown to decrease atopic dermatitis symptoms linked with mite exposure , in patients with mild - to - moderate disease [ 70 ] .", "label": "", "metadata": {}, "score": "74.35702"}
{"text": "10.4049/jimmunol.180.8.5211 .PubMed View Article .Haselden BM , Kay AB , Larch\u00e9 M : Immunoglobulin E - independent major histocompatibility complex - restricted T cell peptide epitope - induced late asthmatic reactions .", "label": "", "metadata": {}, "score": "74.40933"}
{"text": "D Larenas - Linnemann declares she receives speaker fees from MSD , ALK ; travel grants from MSD , Stallergenes , ALK , Allerquim ; and is on the advisory board of Hollister - Stier .", "label": "", "metadata": {}, "score": "74.44047"}
{"text": "Durham SR , Emminger W , Kapp A , Colombo G , de Monchy JG , Rak S , Scadding GK , Andersen JS , Riis B , Dahl R : Long - term clinical efficacy in grass pollen - induced rhinoconjunctivitis after treatment with SQ - standardized grass allergy immunotherapy tablet .", "label": "", "metadata": {}, "score": "74.46922"}
{"text": "L Rosenwasser declares he has no competing interests .He has received travel grants from HAL Allergy , The Netherlands / Germany , and Allergopharma , Germany ; and he is a consultant of HAL - Allergy , The Netherlands , LETI - Pharma / Novartis , Germany ; Bencard , Germany ; Stallergenes , France ; and MEDA - Pharma , Germany .", "label": "", "metadata": {}, "score": "74.51613"}
{"text": "Currently the status quo does not reflect this prerequisite for successful vertical integration of allergy care .Introduction .Over the last 50 years or so , allergic diseases have increased to epidemic proportions globally , as clearly demonstrated in longitudinal population studies [ 143 ] with a concomitant rise in hospital admissions for severe disease [ 144 ] .", "label": "", "metadata": {}, "score": "74.57051"}
{"text": "Volunteers and peripheral blood mononuclear cell ( PBMC ) culture .Atopic allergic volunteers were sensitized to both grass pollen and house dust mite ( by skin prick tests and/or specific IgE ) .", "label": "", "metadata": {}, "score": "74.598885"}
{"text": "New applications are being pursued , encompassing the development of sublingual tablets for mite and ragweed pollen allergies , as well as the evaluation of SLIT as a treatment of asthma .", "label": "", "metadata": {}, "score": "74.65784"}
{"text": "Details of the other trials can be found in the table .SCIT versus SLIT for respiratory allergy .Yukselen et al .[ 62 ] conducted an RDBPC comparison between HDM SCIT and SLIT with a double - blind double - dummy design and concluded that both active treatments are effective , SCIT more so than SLIT .", "label": "", "metadata": {}, "score": "74.681404"}
{"text": "In many medical schools , the subject of allergy is not given a high priority or even included in the medical curriculum .This is compounded by the paucity of allergy education given to or acquired by those working in the community setting [ 151 - 153 ] .", "label": "", "metadata": {}, "score": "74.72918"}
{"text": "However , the panel also raised some questions concerning how the efficacy / safety profile of SLIT compares to that of SCIT and how applicable a single grass allergen tablet will be in treating polysensitized patients , who represent the majority of individuals undergoing SCIT in the US [ 299 ] .", "label": "", "metadata": {}, "score": "74.797104"}
{"text": "However , the cost / benefit ratio of such an approach in the long term has to be confirmed .Reasons for poor adherence to SLIT have been addressed in a survey carried out among Italian allergists [ 265 ] : in addition to the need for education and regular follow - up , the survey highlights issues such as the tolerability and the treatment schedule .", "label": "", "metadata": {}, "score": "74.9164"}
{"text": "It is imperative that clear educational messages are made available to health care planners and the general public concerning what is , and is not , allergic disease and what treatments are and are not effective [ 156 ] .", "label": "", "metadata": {}, "score": "74.9202"}
{"text": "The major issues influencing patient adherence to SLIT are thought to be the patient 's perception of clinical efficacy , cost , and side effects [ 265 , 266 ] .", "label": "", "metadata": {}, "score": "74.95114"}
{"text": "68 , no . 1 , pp .33 - 40 , 1981 .View at Google Scholar .J. W. Georgitis , R. E. Reisman , and W. F. Clayton , \" Local intranasal immunotherapy for grass - allergic rhinitis , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "75.1387"}
{"text": "In a third double - blind study involving 105 patients , SLIT lead to a significant improvement over placebo in symptoms of rhinitis and conjunctivitis due to grass and rye pollen allergies .", "label": "", "metadata": {}, "score": "75.14038"}
{"text": "In a third double - blind study involving 105 patients , SLIT lead to a significant improvement over placebo in symptoms of rhinitis and conjunctivitis due to grass and rye pollen allergies .", "label": "", "metadata": {}, "score": "75.14038"}
{"text": "In a third double - blind study involving 105 patients , SLIT lead to a significant improvement over placebo in symptoms of rhinitis and conjunctivitis due to grass and rye pollen allergies .", "label": "", "metadata": {}, "score": "75.14038"}
{"text": "In a third double - blind study involving 105 patients , SLIT lead to a significant improvement over placebo in symptoms of rhinitis and conjunctivitis due to grass and rye pollen allergies .", "label": "", "metadata": {}, "score": "75.14038"}
{"text": "In a third double - blind study involving 105 patients , SLIT lead to a significant improvement over placebo in symptoms of rhinitis and conjunctivitis due to grass and rye pollen allergies .", "label": "", "metadata": {}, "score": "75.14038"}
{"text": "GP , DL - L , MC , and JB contributed Chapter 4 .LC , GP , and RGvW contributed Chapter 5 .SRD , GWC , EV , and UW contributed Chapter 6 .", "label": "", "metadata": {}, "score": "75.21542"}
{"text": "For those reasons combined , our working hypothesis is that recombinant allergens to be used sublingually should rather be produced in a wild - type ( i.e. , native ) conformation in order to mimick the natural allergen [ 21 , 22 ] .", "label": "", "metadata": {}, "score": "75.30741"}
{"text": "In GRADE , all clinical trials - irrespective of their design - are considered , and their quality of evidence is established according to defined parameters ( Table 9 ) [ 126 ] .", "label": "", "metadata": {}, "score": "75.374374"}
{"text": "Table 9 .Evidence models used to establish guidelines for sublingual immunotherapy .Guidelines on immunotherapy .Since the publication of the original WAO sublingual immunotherapy ( SLIT ) paper [ 9 ] , several new guidelines on allergen immunotherapy ( AIT ) have been published in which SLIT has been taken into account .", "label": "", "metadata": {}, "score": "75.40964"}
{"text": "46 , pp .17908 - 17912 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . D. R. Wilson , M. T. Lima , and S. R. Durham , \" Sublingual immunotherapy for allergic rhinitis : systematic review and meta - analysis , \" Allergy , vol .", "label": "", "metadata": {}, "score": "75.492615"}
{"text": "10.1046/j.1365 - 2222.1998.00407.x .PubMed View Article .Kahlert H , Stuwe H - T , Cromwell O , Fiebig H : Reactivity of T cells with grass pollen allergen extract and allergoid .", "label": "", "metadata": {}, "score": "75.50222"}
{"text": "Email updates .Sublingual immunotherapy : World Allergy Organization position paper 2013 update .Abstract .Furthermore , \" Raising public awareness about sublingual immunotherapy \" , as a need for our patients , and strategies to increase awareness of allergen immunotherapy ( AIT ) among patients , the medical community , all healthcare stakeholders , and public opinion , are also reported in detail .", "label": "", "metadata": {}, "score": "75.51039"}
{"text": "Note that gastrointestinal symptoms associated with SLIT can be classified as either local reactions , if only oromucosal symptoms are present , or as a systemic reaction , if occurring in conjunction with other systemic symptoms .", "label": "", "metadata": {}, "score": "75.55525"}
{"text": "32 , no .4 , pp .248 - 262 , 1977 .View at Google Scholar \u00b7 View at Scopus .J. A. Nickelsen , S. Goldstein , and U. Mueller , \" Local intranasal immunotherapy for ragweed allergic rhinitis .", "label": "", "metadata": {}, "score": "75.55711"}
{"text": "Candidate markers are facilitated allergen binding ( FAB ) inhibition , functional assays of inhibitory IgG4 and IgE - blocking factor , and basophil sensitivity [ 38 , 236 ] , but further investigation is required .", "label": "", "metadata": {}, "score": "75.61073"}
{"text": "More specifically , SLIT significantly reduces both rhinoconjunctivitis symptoms as well as the need for symptomatic medication .Specifically , treatment - related adverse events include frequent ( i.e. , in more that 60 % of patients ) but moderate local reactions in the form of throat irritation , ear pruritus , or tongue oedema [ 6 ] .", "label": "", "metadata": {}, "score": "75.66963"}
{"text": "Effector cells in the target organ .Eosinophils and inflammatory mediators are elevated in nasal lavage fluid and nasal biopsies after nasal allergen challenge and during seasonal pollen exposure [ Chapter 3 of ref .", "label": "", "metadata": {}, "score": "75.714584"}
{"text": "PubMed View Article .Canonica GW , Bousquet J , Mullol J , Scadding GK , Virchow JC : A survey of the burden of allergic rhinitis in Europe .", "label": "", "metadata": {}, "score": "75.82288"}
{"text": "We firmly believe that in time , the remaining question marks over the efficacy of AIT in the treatment of AR induced by other allergens ( for example , house dust mite allergens ) will be dispelled by methodical clinical investigation .", "label": "", "metadata": {}, "score": "75.88527"}
{"text": "In humans , LCs have similarly been described in the mucosa itself , whereas myeloid and plasmacytoid DCs are less abundant [ 35 - 38 ] .", "label": "", "metadata": {}, "score": "75.99927"}
{"text": "In parallel , second - generation vaccines based on recombinant allergens are being investigated to treat birch pollen allergies .These vaccines will associate recombinant allergens in a native conformation , together with Th1/T Reg adjuvants and/or mucoadhesive particulate vector systems .", "label": "", "metadata": {}, "score": "76.10547"}
{"text": "ARIA 2010 is based on publications up until 2009 and inevitably lacks the inclusion of several recent high - quality SLIT trials , which are likely to influence the next update .", "label": "", "metadata": {}, "score": "76.13783"}
{"text": "What is SLIT ?SLIT ( Sublingual Immunotherapy ) also helps to desensitize your immune system to the specific allergens you react to .Rather than using shots , SLIT ( also known as \" allergy drops \" ) uses either drops or tablets ( made from allergen extracts ) , which are then placed under the tongue .", "label": "", "metadata": {}, "score": "76.19759"}
{"text": "10.1111/j.1365 - 2222.2008.03132.x .PubMed View Article .Gallego MT , Iraola V , Himly M , Robinson DS , Badiola C , Garc\u00eda - Robaina JC , Briza P , Carn\u00e9s J : Depigmented and polymerised house dust mite allergoid : allergen content , induction of IgG4 and clinical response .", "label": "", "metadata": {}, "score": "76.201904"}
{"text": "Classification and frequency of SLIT adverse events .One of the purported advantages of SLIT over SCIT is greater safety , which allows for administration of this treatment outside of the medical setting .", "label": "", "metadata": {}, "score": "76.30653"}
{"text": "Adherence to prescriptions is crucial for all long - term treatments , and this is particularly true for SLIT , which is managed at home by the patients themselves .", "label": "", "metadata": {}, "score": "76.34147"}
{"text": "Confounding elements that can affect clinical symptoms due to house dust mites are polysensitization , in particular to pets , and allergen avoidance measures because , although not clearly effective , they may be beneficial to some subjects [ 215 , 240 - 242 ] .", "label": "", "metadata": {}, "score": "76.35866"}
{"text": "Effective SIT is thought to act through regulatory T cells ( Tregs ) rather than activation of effector T cells .There is no published data on the activity of modified extracts on Tregs .", "label": "", "metadata": {}, "score": "76.41138"}
{"text": "135 ] compared the efficacy of oral immunotherapy ( OIT ) versus SLIT for cow 's milk allergy in children .This study showed that OIT was superior to SLIT alone at inducing desensitization to cow 's milk , but desensitization was lost as early as 1 week off therapy .", "label": "", "metadata": {}, "score": "76.56804"}
{"text": "The outcomes of these preventive intervention studies will provide evidence as to whether or not SLIT can play a role in the primary or secondary prevention of atopic diseases .", "label": "", "metadata": {}, "score": "76.68312"}
{"text": "6 , pp .163 - 170 , 2009 .View at Google Scholar \u00b7 View at Scopus . A. M. I. Mowat , L. A. Parker , H. Beacock - Sharp , O. R. Millington , and F. Chirdo , \" Oral tolerance : overview and historical perspectives , \" Annals of the New York Academy of Sciences , vol .", "label": "", "metadata": {}, "score": "76.88503"}
{"text": "The concept of severe chronic upper airway disease ( SCUAD ) has been proposed to indicate patients whose allergic rhinitis is uncontrolled despite adequate guideline - based pharmacologic treatment [ 215 ] .", "label": "", "metadata": {}, "score": "76.91502"}
{"text": "A wide range of secondary outcomes are used in clinical trials , but few are validated or standardized .The item \" days with severe symptoms \" ( or worst days ) has recently been introduced to describe the treatment effect on the most troublesome days in the pollen season [ 253 ] .", "label": "", "metadata": {}, "score": "77.26798"}
{"text": "A European Declaration on Immunotherapy .Designing the future of allergen specific immunotherapy .Abstract .Background .Over the last 100 years , several persistent misconceptions or ' false beliefs ' have built up around allergen immunotherapy and its use in allergic rhinitis .", "label": "", "metadata": {}, "score": "77.32941"}
{"text": "After the patent expires on a biological therapeutic product , similar products may emerge on the market .These products are not generics , but are rather defined as \" biosimilars \" by the major regulatory authorities worldwide [ 323 ] .", "label": "", "metadata": {}, "score": "77.37651"}
{"text": "In recent years , however , numerous well - designed studies of SLIT have been reported , causing the method to gain increasing acceptance among conventional allergists .", "label": "", "metadata": {}, "score": "77.469185"}
{"text": "In recent years , however , numerous well - designed studies of SLIT have been reported , causing the method to gain increasing acceptance among conventional allergists .", "label": "", "metadata": {}, "score": "77.469185"}
{"text": "In recent years , however , numerous well - designed studies of SLIT have been reported , causing the method to gain increasing acceptance among conventional allergists .", "label": "", "metadata": {}, "score": "77.469185"}
{"text": "In recent years , however , numerous well - designed studies of SLIT have been reported , causing the method to gain increasing acceptance among conventional allergists .", "label": "", "metadata": {}, "score": "77.469185"}
{"text": "In recent years , however , numerous well - designed studies of SLIT have been reported , causing the method to gain increasing acceptance among conventional allergists .", "label": "", "metadata": {}, "score": "77.469185"}
{"text": "Local side effects are the most frequent adverse reactions associated with SLIT , and these local reactions can be severe and/or bothersome enough to cause treatment discontinuation .", "label": "", "metadata": {}, "score": "77.52696"}
{"text": "Quality of SLIT meta - analyses and clinical trials .The 3 types of scientific sources used to develop the guidelines reviewed above are other guidelines , systematic reviews , and clinical trials .", "label": "", "metadata": {}, "score": "77.55711"}
{"text": "P Schmid - Grendelmeier declares he has served as consultant for Phadia Thermo Fisher AG , Allergopharma Germany , ALK - Abello Denmark , and Stallergenes France .", "label": "", "metadata": {}, "score": "77.65063"}
{"text": "Thus , birch pollen SLIT in one study resulted in the induction of CD25 + FOXP3 + T cells at 4 weeks [ 22 ] .", "label": "", "metadata": {}, "score": "77.776436"}
{"text": "SR Durham declares he has received via Imperical College London consultancy fees from Merck , ALK Abello , Stallergenes , Circassia , Biomay , Boehringer Ingelheim , and lecture fees from Merck and GSK .", "label": "", "metadata": {}, "score": "78.041374"}
{"text": "Noon L : Prophylactic inoculation against hay fever .Lancet 1911 , 1 : 1572 - 1573 .View Article .Freeman J : Further observation on the treatment of hay - fever by hypodermic inoculation of pollen vaccine .", "label": "", "metadata": {}, "score": "78.064545"}
{"text": "Valovirta E , Korhonen K , Kuitunen M , Kukkonen - Harjula K , Lammintausta K , Pallasaho P , Ralli P , Savolainen J , Toskala E , Virtanen T : [ Update on current care guidelines : allergen specific immunotherapy].", "label": "", "metadata": {}, "score": "78.12005"}
{"text": "False belief # 3 : ' Sublingual allergen immunotherapy is not efficacious in allergic rhinitis ' .The sometimes conflicting results of studies published before the 1980s ( often with small study populations and non - optimal trial designs ) may have been responsible for lingering doubt as to the efficacy of SLIT and little was then known about AIT 's mechanism of action .", "label": "", "metadata": {}, "score": "78.218376"}
{"text": "The great potential advantage of SLIT over allergy shots is that SLIT does not involve needles ; this makes it less unpleasant and also capable of being done at home rather than at a doctor 's office .", "label": "", "metadata": {}, "score": "78.273415"}
{"text": "The great potential advantage of SLIT over allergy shots is that SLIT does not involve needles ; this makes it less unpleasant and also capable of being done at home rather than at a doctor 's office .", "label": "", "metadata": {}, "score": "78.273415"}
{"text": "The great potential advantage of SLIT over allergy shots is that SLIT does not involve needles ; this makes it less unpleasant and also capable of being done at home rather than at a doctor 's office .", "label": "", "metadata": {}, "score": "78.273415"}
{"text": "The great potential advantage of SLIT over allergy shots is that SLIT does not involve needles ; this makes it less unpleasant and also capable of being done at home rather than at a doctor 's office .", "label": "", "metadata": {}, "score": "78.273415"}
{"text": "The great potential advantage of SLIT over allergy shots is that SLIT does not involve needles ; this makes it less unpleasant and also capable of being done at home rather than at a doctor 's office .", "label": "", "metadata": {}, "score": "78.273415"}
{"text": "A double blind study , \" Allergy , vol .41 , no .4 , pp .271 - 279 , 1986 .View at Google Scholar \u00b7 View at Scopus . E. Taudorf , L. C. Laursen , and A. Lanner , \" Oral immunotherapy in birch pollen hay fever , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "78.29151"}
{"text": "10.1111/j.1365 - 2222.2010.03521.x .PubMed View Article .Pfaar O , Urry Z , Robinson DS , Sager A , Richards D , Hawrylowicz CM , Br\u00e4utigam M , Klimek L : A randomized placebo - controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy .", "label": "", "metadata": {}, "score": "78.30829"}
{"text": "The process of registration of AIT products started just a few years ago in many countries .Although the patent expiration is not an immediate problem , it is critical to have AIT products ( which are biological and biotechnological products ) in the category of biosimilars to preserve the quality of the treatments provided to allergic patients .", "label": "", "metadata": {}, "score": "78.368416"}
{"text": "Sublingual immunotherapy ( SLIT ) represents a form of therapeutic vaccination aiming to a long - term allergen - specific immunomodulation in patients with allergic rhinoconjuctivitis , with or without moderate asthma [ 6 ] .", "label": "", "metadata": {}, "score": "78.44881"}
{"text": "A reduced recruitment and activation of inflammatory cells in target mucosae has been observed following allergen - specific immunotherapy [ 48 - 50 ] .Specifically , successful SLIT has been associated with a decrease in the recruitment of mast cells ( both tryptase / chymase+ or tryptase+ only ) , basophils , and eosinophils in the skin , nose , eye , and bronchial mucosae [ 21 , 43 ] .", "label": "", "metadata": {}, "score": "78.46344"}
{"text": "GWC , PS - G , NR , and CEBC contributed Chapter 8 .YO and DR contributed Chapter 9 .MC , EC , MB and SB contributed Chapter 10 .", "label": "", "metadata": {}, "score": "78.52623"}
{"text": "British experts state that SCIT and SLIT have been shown to give long - lasting benefit for some years after treatment is stopped .However , for asthmatic patients the risk / benefit balance is less favorable than for patients with rhinitis , and therefore immunotherapy for asthma is not routinely recommended in the United Kingdom .", "label": "", "metadata": {}, "score": "78.62619"}
{"text": "The study was approved by Guy 's Hospital Ethics Committee and all volunteers gave written consent .Skin prick tests were performed using Soluprick ( ALK Horsholm , Denmark ) and specific IgE was measured using immunoCAP ( Phadia , Uppsala , Sweden ) .", "label": "", "metadata": {}, "score": "78.637634"}
{"text": "11 , pp .1819 - 1829 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . C. M\u00f6ller , S. Dreborg , H. A. Ferdousi et al . , \" Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis ( the PAT - Study ) , \" Journal of Allergy and Clinical Immunology , vol .", "label": "", "metadata": {}, "score": "78.86824"}
{"text": "Sublingual immunotherapy ( SLIT ) has been shown to be effective in reducing symptoms and medication requirements and in improving quality of life in adults and children with seasonal allergic rhinitis .", "label": "", "metadata": {}, "score": "78.97043"}
{"text": "SLIT represents an effective and well - tolerated treatment for seasonal allergic rhinoconjunctivitis in adults , but studies performed in children in primary care have not yielded the same degree of success as in adults for HDM allergy [ 53 ] or for grass pollen allergy [ 182 ] .", "label": "", "metadata": {}, "score": "79.07688"}
{"text": "153 - 161 , 1987 .View at Google Scholar . H. Deuschl and S. G. O. Johansson , \" Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen .", "label": "", "metadata": {}, "score": "79.137505"}
{"text": "Randomized clinical trials in rhinoconjunctivitis .Assessment of Allergen Exposure .The level of pollen exposure should be taken into account when interpreting symptom scores in studies of AIT to treat pollen allergies .", "label": "", "metadata": {}, "score": "79.29712"}
{"text": "Local adverse reactions are often the reason cited for treatment discontinuation in both RDBPC and observational studies [ 69 , 74 , 75 ] .Similar to the need for a grading system for systemic events , a uniform system for grading the severity of local AEs was perceived as necessary for uniform reporting and classification of SLIT local adverse reactions .", "label": "", "metadata": {}, "score": "79.59634"}
{"text": "707 - 713 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . D. Larenas - Linnemann , \" Oralair Birch , a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen , \" Current Opinion in Investigational Drugs , vol .", "label": "", "metadata": {}, "score": "79.789185"}
{"text": "Poor sleep is a particular problem .In a study in France , 44 % of AR patients reported feeling tired after a night 's sleep and were also more prone to anxiety and depression [ 6 ] .", "label": "", "metadata": {}, "score": "79.79921"}
{"text": "10.1034/j.1398 - 9995.2003.00240.x .PubMed View Article .Akdis CA , Akdis M : Mechanisms of allergen - specific immunotherapy .J Allergy Clin Immunol .", "label": "", "metadata": {}, "score": "79.864334"}
{"text": "The grade is based on the organ system(s ) involved and severity and is to be determined by the physician 's clinical judgment after the event is over .", "label": "", "metadata": {}, "score": "79.88179"}
{"text": "T Reg cells induced during immunotherapy are type 1 ( Tr1 ) cells producing high levels of IL-10 and/or transforming growth factor- \u03b2 ( TGF- \u03b2 ) , known to decrease IgE production and to enhance IgG4 and IgA production , respectively [ 42 , 43 ] .", "label": "", "metadata": {}, "score": "79.89798"}
{"text": "Tonnel AB , Scherpereel A , Douay B , et al .Allergic rhinitis due to house dust mites : evaluation of the efficacy of specific sublingual immunotherapy .", "label": "", "metadata": {}, "score": "79.90428"}
{"text": "Tonnel AB , Scherpereel A , Douay B , et al .Allergic rhinitis due to house dust mites : evaluation of the efficacy of specific sublingual immunotherapy .", "label": "", "metadata": {}, "score": "79.90428"}
{"text": "Tonnel AB , Scherpereel A , Douay B , et al .Allergic rhinitis due to house dust mites : evaluation of the efficacy of specific sublingual immunotherapy .", "label": "", "metadata": {}, "score": "79.90428"}
{"text": "Tonnel AB , Scherpereel A , Douay B , et al .Allergic rhinitis due to house dust mites : evaluation of the efficacy of specific sublingual immunotherapy .", "label": "", "metadata": {}, "score": "79.90428"}
{"text": "Tonnel AB , Scherpereel A , Douay B , et al .Allergic rhinitis due to house dust mites : evaluation of the efficacy of specific sublingual immunotherapy .", "label": "", "metadata": {}, "score": "79.90428"}
{"text": "PubMed View Article .Van Bever HPS , Lee BW , Shek L : Viewpoint : the future of research in pediatric allergy : what should the focus be ?", "label": "", "metadata": {}, "score": "79.94118"}
{"text": "Three of the 25 papers only evaluated the safety of SLIT .Of the 21 that evaluated efficacy , the prime allergic disease was allergic rhinitis / rhinoconjunctivitis in 14 papers , allergic asthma in 3 , both asthma and rhinitis in 3 , and food allergy in 2 ( Table 8 ) .", "label": "", "metadata": {}, "score": "79.94467"}
{"text": "False belief # 6 : ' Allergen immunotherapy is not appropriate in polysensitized patients ' .This misconception is only slightly less sensible than saying ' antihistamines are not appropriate in polysensitized patients . '", "label": "", "metadata": {}, "score": "80.110664"}
{"text": "His long scientific and medical career puts him in a unique position to evaluate passing fads and hard facts .Dr. Moises A. Calderon and Dr. Pascal Demoly are active younger members of the European Association of Allergy and Clinical Immunology ( EAACI ) and have a particular focus on assessing the quality of research evidence in the treatment of respiratory allergies .", "label": "", "metadata": {}, "score": "80.13595"}
{"text": "Cochrane meta - analyses , conducted under the auspices of the Cochrane Collaboration Group , must meet the highest quality standards .An updated Cochrane meta - analysis on SLIT for allergic rhinitis published by Radulovic et al . in 2011 included 42 randomized , double - blind , placebo - controlled trials .", "label": "", "metadata": {}, "score": "80.32257"}
{"text": "2006 Oct 11 .[ Epub ahead of print ] .Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "80.352615"}
{"text": "2006 Oct 11 .[ Epub ahead of print ] .Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "80.352615"}
{"text": "2006 Oct 11 .[ Epub ahead of print ] .Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "80.352615"}
{"text": "2006 Oct 11 .[ Epub ahead of print ] .Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "80.352615"}
{"text": "2006 Oct 11 .[ Epub ahead of print ] .Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "80.352615"}
{"text": "Competing interests .Authors declare no competing financial interests .Authors ' contributions .CMH and DS conceived and secured funding for the project .ZLU , DFR , CB , MEM , JC , CMH and DSR contributed to the design of , performed and analyzed data from all experiments .", "label": "", "metadata": {}, "score": "80.365204"}
{"text": "For this reason , Wambre and colleagues have used T cell surface / intracellular marker expression with or without associated tetramer staining to characterize subjects allergic to grass pollen and mites , with the aim of distinguishing antigen - specific T cells from bystander T cell responses [ 29 ] .", "label": "", "metadata": {}, "score": "80.54889"}
{"text": "False belief # 8 : ' Allergic disease is constant over a patient 's lifetime ' .There is sound epidemiological evidence to show that the activity of allergic respiratory diseases changes with age and that children develop and/or display atopy within the first years or even months of life [ 25 ] .", "label": "", "metadata": {}, "score": "80.56717"}
{"text": "Even the perception of allergen - specific immunotherapy among GPs can be relevant to the adherence to SLIT :In a different Italian survey , an 11-item questionnaire on AIT was emailed to 200 GPs .", "label": "", "metadata": {}, "score": "80.63425"}
{"text": "One further study with dust mite SLIT in 138 children aged 2 - 5 years with asthma or rhinitis showed only mild to moderate local AEs [ 107 ] .", "label": "", "metadata": {}, "score": "80.83848"}
{"text": "Oral tissues contain limited numbers of mast cells and eosinophils , mostly located in submucosal areas , thereby explaining the good safety profile of SLIT .", "label": "", "metadata": {}, "score": "81.1467"}
{"text": "In 2011 , a flurry of events and publications marked the centenary of Leonard Noon and John Freeman 's ground - breaking papers in The Lancet - the first scientific descriptions of clinically effective allergen immunotherapy ( AIT ) for grass - pollen - induced allergic rhinoconjunctivitis [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "81.60419"}
{"text": "G Passalacqua declares he has received consulting or lecture fees from Lofarma S.p . A. , Stallergenes Italia , GSK , MSD , Novartis , though unrelated to this document .", "label": "", "metadata": {}, "score": "81.76074"}
{"text": "An introductory address by Professor Guido Rasi , Executive Director , European Medicines Agency ( EMA ) .Immunotherapy and Biologics represent some of the most important hot topics in the field of medicine .", "label": "", "metadata": {}, "score": "81.931885"}
{"text": ": Allergic Rhinitis and its Impact on Asthma ( ARIA ) 2008 update ( in collaboration with the World Health Organization , GA(2)LEN and AllerGen ) .", "label": "", "metadata": {}, "score": "81.970604"}
{"text": "There are no universally accepted criteria by which a treatment is classified as part of \" alternative \" rather than conventional medicine .Sublingual immunotherapy ( SLIT ) falls primarily in the last camp .", "label": "", "metadata": {}, "score": "82.02173"}
{"text": "There are no universally accepted criteria by which a treatment is classified as part of \" alternative \" rather than conventional medicine .Sublingual immunotherapy ( SLIT ) falls primarily in the last camp .", "label": "", "metadata": {}, "score": "82.02173"}
{"text": "There are no universally accepted criteria by which a treatment is classified as part of \" alternative \" rather than conventional medicine .Sublingual immunotherapy ( SLIT ) falls primarily in the last camp .", "label": "", "metadata": {}, "score": "82.02173"}
{"text": "There are no universally accepted criteria by which a treatment is classified as part of \" alternative \" rather than conventional medicine .Sublingual immunotherapy ( SLIT ) falls primarily in the last camp .", "label": "", "metadata": {}, "score": "82.02173"}
{"text": "There are no universally accepted criteria by which a treatment is classified as part of \" alternative \" rather than conventional medicine .Sublingual immunotherapy ( SLIT ) falls primarily in the last camp .", "label": "", "metadata": {}, "score": "82.02173"}
{"text": "The immunotherapy practice guidelines state that \" Immunotherapy can be considered in patients with immunodeficiency and autoimmune disorders \" [ 102 ] .Most of these studies were based on SCIT , but these findings should apply to SLIT because the immunological mechanism between the routes are thought to be the similar [ 8 ] .", "label": "", "metadata": {}, "score": "82.04548"}
{"text": "SLIT a Viable Allergy Treatment While sublingual immunotherapy is not currently approved by the FDA , it is a viable option for allergy patients who are sensitive to one allergen .", "label": "", "metadata": {}, "score": "82.18893"}
{"text": "The WAO SLIT document presented in this issue of the World Allergy Organization Journal , and the EAACI \" Task Force Report on Clinical Outcomes to be used in studies of Allergen Products \" , represent relevant contributions to answer the recommendations emerging from this workshop .", "label": "", "metadata": {}, "score": "82.28639"}
{"text": "Recombinant allergens .Modern technology has enabled the synthesis of recombinant proteins whose main advantages are their fully characterized physical , chemical , and immunologic properties .", "label": "", "metadata": {}, "score": "82.496"}
{"text": "Some title or credential would indicate that these GPs have reached level higher in the field of allergy than would be the case for most GPs [ 209 ] .", "label": "", "metadata": {}, "score": "82.56828"}
{"text": "PubMed View Article .Durham SR : GT-08 investigators : Sustained effects of grass pollen AIT .Allergy 2011 , 66 : 50 - 52 .", "label": "", "metadata": {}, "score": "82.60477"}
{"text": "However , some SLIT studies have not shown increases in IgG levels , particularly following house dust mite immunotherapy [ 18 ] .In a study of high - dose grass pollen SLIT , increases in grass pollen - specific IgA2 as well as IgG and IgG4 occurred in parallel with local increases in sublingual FOXP3 + Tregs [ 15 ] .", "label": "", "metadata": {}, "score": "82.655815"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Urbanek , K. H. Burgelin , S. Kahle , W. Kuhn , and U. Wahn , \" Oral immunotherapy with grass pollen in enterosoluble capsules .", "label": "", "metadata": {}, "score": "82.879326"}
{"text": "As the full text is in Chinese we could not analyze the exact content of this document .Other guidelines in which immunotherapy is mentioned .", "label": "", "metadata": {}, "score": "82.9627"}
{"text": "Inhibition of basophil activation has been shown following SLIT with a combined grass and mite extract [ 20 ] ; however , another study of grass pollen SLIT [ 21 ] found no changes in basophil activation and no correlation with clinical response to treatment .", "label": "", "metadata": {}, "score": "82.99713"}
{"text": "Perhaps the best evidence for the effectiveness of SLIT involves treatment of allergic rhinitis ( hay fever ) .For example , in a double - blind study of 855 adults with grass allergies , SLIT using grass pollen tablets for approximately 18 weeks markedly reduced allergy symptoms , 1 including nasal congestion and itchy eyes .", "label": "", "metadata": {}, "score": "83.06663"}
{"text": "Perhaps the best evidence for the effectiveness of SLIT involves treatment of allergic rhinitis ( hay fever ) .For example , in a double - blind study of 855 adults with grass allergies , SLIT using grass pollen tablets for approximately 18 weeks markedly reduced allergy symptoms , 1 including nasal congestion and itchy eyes .", "label": "", "metadata": {}, "score": "83.06663"}
{"text": "Perhaps the best evidence for the effectiveness of SLIT involves treatment of allergic rhinitis ( hay fever ) .For example , in a double - blind study of 855 adults with grass allergies , SLIT using grass pollen tablets for approximately 18 weeks markedly reduced allergy symptoms , 1 including nasal congestion and itchy eyes .", "label": "", "metadata": {}, "score": "83.06663"}
{"text": "Perhaps the best evidence for the effectiveness of SLIT involves treatment of allergic rhinitis ( hay fever ) .For example , in a double - blind study of 855 adults with grass allergies , SLIT using grass pollen tablets for approximately 18 weeks markedly reduced allergy symptoms , 1 including nasal congestion and itchy eyes .", "label": "", "metadata": {}, "score": "83.06663"}
{"text": "Perhaps the best evidence for the effectiveness of SLIT involves treatment of allergic rhinitis ( hay fever ) .For example , in a double - blind study of 855 adults with grass allergies , SLIT using grass pollen tablets for approximately 18 weeks markedly reduced allergy symptoms , 1 including nasal congestion and itchy eyes .", "label": "", "metadata": {}, "score": "83.06663"}
{"text": "SLIT is also suggested for selected patients with atopic dermatitis and aeroallergen sensitization , latex allergy , or large local reactions secondary to Hymenoptera venom allergy [ 288 ] .", "label": "", "metadata": {}, "score": "83.121506"}
{"text": "The majority of guidelines recognize SLIT to be safer than SCIT .However , there are 6 reports worldwide of severe systemic reactions to SLIT .", "label": "", "metadata": {}, "score": "83.15373"}
{"text": "10.1111/j.1365 - 2222.2007.02687.x .PubMed View Article .Dormann D , Ebner C , Jarman ER , Montermann E , Kraft D , Reske - Kunz AB : Responses of human birch pollen allergen - reactive T cells to chemically modified allergens ( allergoids ) .", "label": "", "metadata": {}, "score": "83.277954"}
{"text": "Data for some of the experiments with grass pollen extracts has been presented elsewhere [ 7 ] .Depigmented - polymerised house dust mite extract stimulates significantly less PBMC proliferation than unmodified native extract .", "label": "", "metadata": {}, "score": "83.49452"}
{"text": "Failure to meet patients ' needs leads them to seek help from alternative practitioners who may do more harm than good , and often at great expense to the patient .", "label": "", "metadata": {}, "score": "83.74543"}
{"text": "Allergy management .Allergy management consists of a variety of strategies , foremost of which is avoidance of the offending allergen .This , of course , may not be possible , such as with the ubiquitous house dust mite ( HDM ) [", "label": "", "metadata": {}, "score": "83.79692"}
{"text": "Clinical efficacy of SLIT in children : update 2009 to September 2012 .Pediatric SLIT and allergic rhinitis .The efficacy of grass pollen SLIT tablets for seasonal allergic rhinitis in children had already been established in the first WAO SLIT position paper , based primarily on the results of 3 large trials done in Europe [ 124 , 125 , 128 ] .", "label": "", "metadata": {}, "score": "83.86809"}
{"text": "Prevention studies .Allergic rhinoconjunctivitis is a risk factor for the development of asthma , and treatment of the underlying allergy may represent an attractive method of asthma prevention , mainly in the pediatric population .", "label": "", "metadata": {}, "score": "83.93527"}
{"text": "19 Other studies have also shown benefit for hay fever caused by grass pollen or other allergens , 14,21,22 including dust mites and tree pollen .", "label": "", "metadata": {}, "score": "84.327156"}
{"text": "19 Other studies have also shown benefit for hay fever caused by grass pollen or other allergens , 14,21,22 including dust mites and tree pollen .", "label": "", "metadata": {}, "score": "84.327156"}
{"text": "19 Other studies have also shown benefit for hay fever caused by grass pollen or other allergens , 14,21,22 including dust mites and tree pollen .", "label": "", "metadata": {}, "score": "84.327156"}
{"text": "19 Other studies have also shown benefit for hay fever caused by grass pollen or other allergens , 14,21,22 including dust mites and tree pollen .", "label": "", "metadata": {}, "score": "84.327156"}
{"text": "19 Other studies have also shown benefit for hay fever caused by grass pollen or other allergens , 14,21,22 including dust mites and tree pollen .", "label": "", "metadata": {}, "score": "84.327156"}
{"text": "Allergic asthma can be triggered by pet dander , dust and dust mites , pollen and mold .Allergists advise some of their patients to undergo allergy shots ( immunotherapy ) , which help to desensitize the immune system to these asthma triggers .", "label": "", "metadata": {}, "score": "84.383255"}
{"text": "Another large - scale study has also documented the clinical efficacy of SLIT in perennial allergy ( i.e. , to house dust mites ) using a tablet containing extracts from the two common D. pteronyssinus and D. farinae mite species [ 30 ] .", "label": "", "metadata": {}, "score": "84.706985"}
{"text": "e - Delphi exercise .: Research needs in allergy : an EAACI position paper , in collaboration with EFA .: Practical guide to skin prick tests in allergy to aeroallergens .", "label": "", "metadata": {}, "score": "84.79212"}
{"text": "The FDA is not able to \" ensure the safety and effectiveness of a product when prescribed for ' off - label'use . \"In other words , while allergists are allowed to use FDA - approved allergen extracts for SLIT , the FDA can not ensure the safety or effectiveness of allergen extracts used in this procedure .", "label": "", "metadata": {}, "score": "85.157005"}
{"text": "OP , GS , and EV contributed Chapter 12 .MC , RP , GWC , LC , JB , and UW contributed Chapter 13 .", "label": "", "metadata": {}, "score": "85.191376"}
{"text": "Italian investigators studied the congruence between international guidelines and AIT prescription patterns in 518 patients from 34 allergy centers .The investigation focused on the fact that ARIA and GINA guidelines recommend prescribing AIT according to disease severity .", "label": "", "metadata": {}, "score": "85.236496"}
{"text": "A review of SLIT trials performed in the United States ( US ) was recently published [ 130 ] .It highlighted one new high - quality trial conducted among American children with grass - pollen allergic rhinoconjunctivitis [ 40 ] as well as another randomized , double - blind , placebo - controlled ( RDBPC ) trial conducted with a highly concentrated grass pollen sublingual solution [ 54 ] .", "label": "", "metadata": {}, "score": "85.31311"}
{"text": "PubMed View Article .Calderon M , Mosges R , Hellmich M , Demoly P : Towards evidence - based medicine in specific grass pollen immunotherapy .", "label": "", "metadata": {}, "score": "85.40666"}
{"text": "Only few proinflammatory cells ( i.e. , mast cells ( MCs ) or eosinophils ( Eos ) ) are found in oral tissues , and these cells are mostly located in muscular tissues ( Figure 1 ) [ 34 , 38 ] .", "label": "", "metadata": {}, "score": "85.67583"}
{"text": "Ongoing studies are evaluating the role of SLIT in food allergy and oral allergy syndrome .SLIT studies specifically for milk [ 135 ] and peanut [ 134 , 217 ] have shown clinical efficacy and safety .", "label": "", "metadata": {}, "score": "85.91125"}
{"text": "References .J. Freeman , \" Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "86.1467"}
{"text": "Allergy is a set of signs and symptoms triggered by release of chemical mediators from the degranulation of mast cells in response to crosslinking of IgE molecules bound to the membranes of these mast cells by an allergen .", "label": "", "metadata": {}, "score": "86.19515"}
{"text": ": Severe chronic allergic ( and related ) diseases : a uniform approach - a MeDALL - GA2LEN - ARIA position paper .Brito FF , Gimeno PM , Carnes J , Martin R , Fernandez - Caldas E , Lara P , Lopez - Fidalgo J , Guerra F : Olea europaea pollen counts and aeroallergen levels predict clinical symptoms in patients allergic to olive pollen .", "label": "", "metadata": {}, "score": "86.32173"}
{"text": "[ 13 ] recently highlighted that the tonsils and surrounding lymphoid tissue are located in the gateway of both the alimentary and respiratory tracts and may be important for local induction of tolerance to both food and inhalant allergens .", "label": "", "metadata": {}, "score": "86.37796"}
{"text": "5 , pp .1073 - 1079 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus Asthma and allergies typically go hand - in - hand for many asthmatics .", "label": "", "metadata": {}, "score": "86.636345"}
{"text": "PubMed View Article . :Allergic rhinitis and its impact on asthma ( ARIA ) : achievements in 10 years and future needs .J Allergy Clin Immunol 2012 , 130 : 1049 - 1062 .", "label": "", "metadata": {}, "score": "86.82684"}
{"text": "SLIT safety : patient selection and instructions .Careful consideration should also be given to the ability of the patients or their families to adhere to these instructions and the treatment regimen .", "label": "", "metadata": {}, "score": "87.41576"}
{"text": "The Mexican guidelines include an in - depth analysis of the literature following the GRADE system .SLIT is recommended as an alternative to SCIT in children and adults with allergic rhinitis and/or asthma in whom AIT with pollen and/or house dust mite ( HDM ) is indicated , but who reject injection treatment or in whom there might be safety issues with SCIT .", "label": "", "metadata": {}, "score": "87.43987"}
{"text": "The advent of sublingual immunotherapy ( SLIT ) now offers the possibility of once again providing immunotherapy in the community setting .The language of allergy .", "label": "", "metadata": {}, "score": "87.56346"}
{"text": "In general , SLIT appears to be associated with fewer and less severe AEs than SCIT .Oropharyngeal reactions are the most common AEs with SLIT , but other reactions , such as asthma , urticaria , and abdominal pain have been reported .", "label": "", "metadata": {}, "score": "87.84288"}
{"text": "SLIT in young children .Immunotherapy guidelines do not specify a particular lower age limit for initiating AIT .SCIT is often not prescribed to young children , primarily because of concerns that they may have difficulty cooperating with an immunotherapy program and , in particular , in communicating symptoms of systemic reactions .", "label": "", "metadata": {}, "score": "88.4698"}
{"text": "World Health Organization .American academy of Allergy , Asthma and Immunology .Leith E , Bowen T , Butchey J , Fischer D , Kim H , Moote B , Small P , Stark D , Waserman S : Consensus Guidelines on Practical Issues of Immunotherapy - Canadian Society of Allergy and Clinical Immunology ( CSACI ) .", "label": "", "metadata": {}, "score": "88.59206"}
{"text": "Quick Links Connect With Us --Contact Us --Phone Directory --Request for Medical Records --Patient Portal --Classes and Events --Make An Appointment Quality & Privacy --Quality of Care --Patient Rights & Responsibilities --Privacy Policies --Patient Safety --Medication Safety Uses .", "label": "", "metadata": {}, "score": "88.726265"}
{"text": "Authors ' contributions .GWC , LC , and RP are Chairpersons and led the document development .GWC provided new figures for Chapter 1 .", "label": "", "metadata": {}, "score": "88.75395"}
{"text": "A seemingly positive HDM SLIT trial was conducted in Japan , but the scientific quality of this study was GRADE 1 [ 66 ] .Pediatric SLIT and asthma .", "label": "", "metadata": {}, "score": "89.00569"}
{"text": "Similarly lax use of the term by clinicians creates further misunderstanding and misdiagnosis , for example , describing the watering of eyes while cutting onions as an allergic reaction , or suggesting that the flushing of the face on exposure to strong sunlight is a \" solar allergy \" .", "label": "", "metadata": {}, "score": "89.40037"}
{"text": "Additional clinical trials in adult and pediatric patient populations are needed to further document a benefit of SLIT in this indication .Recently , SLIT has also been tested successfully in several new clinical indications , including allergies to latex and food ( e.g. , peach , kiwi , hazelnut ) [ 67 - 69 ] .", "label": "", "metadata": {}, "score": "89.76572"}
{"text": "The average GP currently has limited knowledge concerning SLIT [ 210 ] .Interested primary and secondary care organizations should work towards developing a framework that will lead to greater accessibility and availability of SLIT and improved education of patients and providers alike .", "label": "", "metadata": {}, "score": "89.95279"}
{"text": "Vaccines based on recombinant allergens are particularly suitable when the number of target allergens is limited , which is the case for birch ( Betula verrucosa ) pollen allergy [ 54 ] .", "label": "", "metadata": {}, "score": "90.2594"}
{"text": "Allergic rhinitis is a heterogeneous , under - diagnosed , undertreated , chronic , allergic respiratory condition .If physicians disregard the severity of symptoms , AR sufferers will remain exposed to co - morbidities and poor quality of life .", "label": "", "metadata": {}, "score": "90.42828"}
{"text": "With other seasonal allergens , such as tree pollen allergens , it can be an effective treatment option , but data are rather scarce .No consistent proof of effectiveness is available for SLIT with house dust mite allergens and other perennial allergens [ 274 ] .", "label": "", "metadata": {}, "score": "90.65396"}
{"text": "We gratefully acknowledge the support of the divisional research nurses , Mrs Kheem Jones and Mrs Cherylin Reinholtz .Authors ' original submitted files for images .", "label": "", "metadata": {}, "score": "91.29184"}
{"text": "Several methods have been employed for measuring adherence , but none of them can be assumed as the gold standard .So far , 6 observational studies have specifically addressed this issue [ 75 , 311 - 315 ] .", "label": "", "metadata": {}, "score": "91.64087"}
{"text": "SLIT seems to work best for people who are allergic to one type of allergen , for example grass or dust mite allergy .However , SLIT is not recommended for patients who are sensitive to multiple allergens .", "label": "", "metadata": {}, "score": "92.0812"}
{"text": "Authors ' Affiliations .Department of Allergy and Asthma , MRC and Asthma UK Centre for Mechanisms of Allergic Asthma , Guy 's Campus , King 's College London .", "label": "", "metadata": {}, "score": "92.9346"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Calderon et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd. Induction of Tolerance via the Sublingual Route : Mechanisms and Applications .", "label": "", "metadata": {}, "score": "93.12103"}
{"text": "In summary , since the previous position paper there is now good evidence for long - term efficacy after treatment discontinuation and a disease - modifying effect of SLIT in grass pollen rhinoconjunctivitis .", "label": "", "metadata": {}, "score": "93.77501"}
{"text": "Commitee for medicinal products for human use ( CHMP ) : Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases .", "label": "", "metadata": {}, "score": "93.789734"}
{"text": "Acknowledgements .WAO would like to thank the Chairpersons of the task force that developed this document for their leadership : Giorgio Walter Canonica , MD ; Linda Cox , MD ; and Ruby Pawankar , MD , PhD. The authors acknowledge Naomi Ruff , PhD for her technical editing services .", "label": "", "metadata": {}, "score": "93.90141"}
{"text": "Quick Links Patients & Visitors --Classes & Events --Maps & Directions --Patient Information --Pay Bill Online --Site Map --Registration Health Info --For Physicians --For Employees --Careers --Code Ready --Health Library --Video Library Alternate Name .", "label": "", "metadata": {}, "score": "94.11453"}
{"text": "SLIT has been used extensively in Europe for many years , but is not currently approved by the FDA for use in the United States .", "label": "", "metadata": {}, "score": "94.14469"}
{"text": "Authors ' Affiliations .Section of Allergy and Clinical Immunology , Imperial College London - National Heart and Lung Institute , Royal Brompton Hospital .Allergy Division , Pneumology Department , INSERM U657-University Hospital of Montpellier .", "label": "", "metadata": {}, "score": "94.14713"}
{"text": "If you 're interested in finding out more about SLIT , check with your doctor to see if this treatment would be right for you or your kids .", "label": "", "metadata": {}, "score": "94.715904"}
{"text": "R Pawankar declares she has no competing interests .CE Baena - Cagnani declares he has no competing interests .M Blaiss declares he receives consulting fees from Merck and Circassia and speaker fees from Merck .", "label": "", "metadata": {}, "score": "94.8414"}
{"text": "The updated version of ARIA 2010 [ 292 ] includes the GRADE system for evaluation of the evidence .ARIA 2010 ' suggests ' ( that is , weakly recommends ) the use of SLIT in adults with allergic rhinitis without asthma caused by pollen or HDM allergy and in children with allergic rhinitis caused by pollen allergy .", "label": "", "metadata": {}, "score": "94.852165"}
{"text": "Authors ' contributions .All authors were involved in drafting the manuscript .The authors accept full responsibility for the work and the decision to publish .", "label": "", "metadata": {}, "score": "94.85608"}
{"text": "Clinical Research Facility at Guy 's & St Thomas ' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy 's & St Thomas ' NHS Foundation Trust and King 's College London .", "label": "", "metadata": {}, "score": "95.84908"}
{"text": "False belief # 1 : ' Allergic rhinitis is a trivial , homogenous disease ' .In fact , AR is under - diagnosed and undertreated , and its symptoms are more troublesome than many physicians ( and indeed some patients ) believe .", "label": "", "metadata": {}, "score": "98.58978"}
{"text": "Allergic respiratory disease : asthma and rhinitis .Four studies investigated SLIT in allergic respiratory conditions in children with both allergic rhinitis and asthma [ 47 , 62 , 132 , 133 ] .", "label": "", "metadata": {}, "score": "99.01248"}
{"text": "63 , no .6 , pp .720 - 727 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .", "label": "", "metadata": {}, "score": "100.481865"}
{"text": "149 , no . 8 , pp .545 - 550 , 1990 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "101.011"}
{"text": "Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition .", "label": "", "metadata": {}, "score": "101.480736"}
{"text": "Quick Links Patients & Visitors --Classes & Events --Location --Patient Information --Pay Bill Online --Site Map --Registration Health Info --For Physicians --For Employees --Careers --Code Ready --Health Library --Video Library New medical imaging technology now available at Medical City Dallas Hospital offers whole organ scanning , image quality and speed , allowing Medical City 's physicians to diagnose even the most challenging ... .", "label": "", "metadata": {}, "score": "101.67716"}
{"text": "4 - 12 , 2005 .View at Google Scholar \u00b7 View at Scopus .97 , no . 2 , pp .141 - 148 , 2006 .", "label": "", "metadata": {}, "score": "102.26707"}
{"text": "under the high patronage of His Serene Highness Prince Albert II of Monaco .Hankin CS , Cox L , Lang D , Bronstone A , Fass P , Leatherman B , Wang Z : Allergen immunotherapy and health care cost benefits for children with allergic rhinitis : a large - scale , retrospective , matched cohort study .", "label": "", "metadata": {}, "score": "102.479324"}
{"text": "140 , no .4 , pp .295 - 305 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "103.17738"}
{"text": "Please be aware that this information is provided to supplement the care provided by your physician .It is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "103.268745"}
{"text": "125 , no . 1 - 3 , pp .131 - 138 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "104.37041"}
{"text": "120 , no .6 , pp .1338 - 1345 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "105.7795"}
{"text": "126 , no .5 , pp .969 - 975 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "106.10544"}
{"text": "Frankland 's London home .Bill Frankland has been described as the ' grandfather of allergy ' in the UK , starting in 1946 in the Allergy Department at Saint Mary 's , where he notably pioneered the use of the controlled , randomized clinical trial in this area .", "label": "", "metadata": {}, "score": "108.22237"}
{"text": "Declarations .Acknowledgements .This study was funded by Laboratorios Leti , Spain , including salary support for ZLU .MEM and JC are paid employees of Laboratorios Leti , Spain , and DSR is a paid consultant to Laboratorios Leti .", "label": "", "metadata": {}, "score": "110.641754"}
{"text": "10.1084/jem.189.12.1885 .PubMed PubMed Central View Article .J Exp Med .10.1084/jem.20082901 .PubMed PubMed Central View Article .Copyright .", "label": "", "metadata": {}, "score": "111.2936"}
{"text": "Received 30 May 2011 ; Accepted 23 September 2011 .Copyright \u00a9 2012 Philippe Moingeon and Laurent Mascarell .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "116.65231"}
{"text": "All rights reserved .This content was written by Sherry Vacik .If you wish to use this content in any manner , you need written permission .", "label": "", "metadata": {}, "score": "137.07808"}
